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Abstract
Most current diagnostic assays are singlepiex, or at most, can detect no more 
than a handful of targets simultaneously. There is an increasing demand in diagnostic 
laboratories for multiplex assays to facilitate investigation into the cause of outbreaks 
and in the meantime to obtain valuable epidemiological data e.g. pathotype or 
genotype of the viral agent. As part of this project a multiplex assay, a DNA 
microarray, was developed to enable the simultaneous detection and typing of two 
major quarantine viruses, the zoonotic lyssaviruses and classical swine fever virus 
(CSFV). The microarray was assessed by testing samples from experimentally infected 
animals with lyssa- and CSF- viruses and cell cultures infected with CSF viruses. The 7 
genotypes of lyssaviruses and 10 sub-genotypes of CSFV were correctly identified to 
type.
In a wider context, this study also aimed to assess the value of DNA microarrays 
in investigation of clinical syndromes, especially those in which current diagnostic 
assays had failed to identify a viral agent. Several such cases in terrestrial animals 
were investigated in this project. The microarray successfully identified for the first 
time an equine encephalosis virus outside Southern Africa, a new species of rotavirus 
in red squirrels, a porcine neurotropic sapelovirus in pigs and a parvovirus in goslings 
suffering from high mortality. In conclusion, this study provides supporting evidence 
on the application of microarrays as a versatile multiplex tool to detect and type 
known viruses and screen for re-emerging and novel viral pathogens in disease 
investigations.
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Chapter 1: Introduction
1.1 Detection methods in viroiogy
Laboratory diagnosis of animal disease is carried out for a number of reasons, 
the main reason being to confirm the cause of clinical signs in diseased animals. In 
many cases the laboratory diagnosis would be confirmatory to the clinical diagnosis 
made by a veterinarian, based on the gross clinical signs pre- and possibly post 
mortem. In some cases, especially when clinical signs correspond to  more than one 
viral pathogen, or in infections of unknown aetiology, the laboratory diagnosis 
becomes critical. Moreover, recent advances in antiviral therapeutics summons the 
need for specific viral diagnosis, not only to prevent excess usage of antiviral drugs that 
are expensive and potentially toxic, but also in occasion, to prevent unnecessary use of 
antibiotic therapies. Likewise, in some cases establishing the causative viral agent 
would help in determining the prognosis of the infection. Finally, viral diagnosis is 
important to prevent spread of infections such as rabies, through effective vaccination 
campaigns. Virus isolation in cell culture and a number of other methodologies to 
detect viral antigens, antibody and nucleic acids form the core repertoire of laboratory 
diagnosis of viral infections.
1.1.1 Cell culture
Cell culture dates back to 1949 during which Enders and colleagues performed 
the first cell culture to grow poliomyelitis virus (Enders et al., 1949). Virus isolation in 
cell culture is the only technique capable of producing viable viral isolates that can be 
used for further characterisation such as epidemiological studies and phenotypic 
antiviral susceptibility testing. The growth of virus in cell culture is usually detected by
cytopathic effects (CPE) produced, however, tests such as haemagglutination inhibition 
(HI) and fluorescent antibody test (FAT) are required to confirm replication of the virus.
Multiple viruses can often be detected via cell culture propagation. However, 
under certain instances, excess growth of non-pathogenic viruses in the sample could 
mask the growth and detection of the causative viral agents. There are also additional 
drawbacks; no single cell line can support the growth of all clinically relevant viruses 
and multiple cell lines have to be regularly passaged and maintained, which may not 
be in the scope of many diagnostic laboratories. Not all viruses produce cytopathic 
effects, can be easily cultured, or have the ability to haemagglutinate. Some viruses 
such as cytomegalovirus (CMV), take 1-3 weeks to be detected in cell culture (OIE, 
2008b). The success of cell culture is also dependent on specimen maintenance during 
transport, as the virus has to be viable to be cultured. These shortcomings have limited 
the usage of cell culture as a frontline diagnostic tool and at present the technique is 
mostly applied for detailed characterisation of cultivatable viruses.
1.1.2 Antigen detection
Viral structural proteins that make up the viral capsid contain the antigenic 
determinant sites (epitopes), which play an important role in diagnosis. Viral antigen 
(epitopes that elicit an immune response) detection is a well-established and useful 
method for directly demonstrating the presence of viruses in infected tissues and body 
fluids, and for virus typing in tissue-culture isolates. The in situ detection of antigens in 
tissues offers a number of advantages such as quick results, ability to  perform 
retrospective studies on stored specimens, and potential to detect nonviable
organisms (Deborah & Edward, 1991). The only disadvantage of this technique lies in 
the usage of chemically fixed tissues where the structural integrity of the epitopes due 
to the treatment can sometimes be altered, leading to mismatches with the antibody 
(Louis et al., 2000). This can however, be overcome by use of frozen tissue sections or 
employment of antigen retrieval techniques such as proteolytic enzyme digestion.
Detection of antigen in blood and other body fluids, and typing of tissue culture 
isolates can be achieved by popular immunoassay techniques such as 
immunoperoxidase staining (IPX), FAT and enzyme-linked immunosorbent assay 
(ELISA). In IPX (Figure I.IA ), the antigen is captured by an antibody-coated matrix and 
the antigen-antibody complex is detected by a secondary horseradish peroxidase- 
labelled antibody and colorimetric reactions. In FAT, (Figure I.IB ) a secondary 
fluorescent-labelled antibody, which fluoresces upon excitation by light of a particular 
wavelength, detects the antigen-antibody complex.
A;
B;
■ '
Figure 1.1:
I.IA ; Immunoperoxidase (IPX) staining of viral antigen in alveolar epithelial cells 
infected with avian influenza A (H5N1) virus. lOOx (Uiprasertkul et al., 2007).
I.IB ; Fluorescent antibody test (FAT) of equine herpesvirus-1 (EHV-1) showing CPE in 
rabbit kidney cells (Kathy, 1998).
One of the most popular immunoassays is the enzyme-linked immunosorbent 
assay (ELISA) first described in 1971 (Engvall & Perlmann, 1971; Weemen & Schuurs, 
1971). This technique involves immobilisation of a known standard antibody (that is 
complementary to the antigen under detection), on to the wells of a microtiter plate. 
Upon addition of the test sample followed by subsequent washing steps, an enzyme- 
linked antibody that is complementary to the test antigen is added to the mixture. 
Upon addition of substrate the presence of test antigen is detected and quantified by 
the colour produced due to the enzymatic reaction. The technique widely gained 
popularity due to its high sensitivity. Antigen-capture ELISA is quick and takes only 3 to 
4 hours to accomplish. Conjunction of immunoreactants with the vitamin biotin 
(which has high affinity to streptavidin) can achieve an even higher sensitivity 
compared to standard enzyme labels (Scalia et al., 1995). As an alternative to 
streptavidin, the compound anti-biotin that shares similar affinity of streptavidin, is 
also widely used in commercial kits. A similar antigen detection method using antigen 
capture immunomagnetic beads is now popular and is one of the well-accepted 
methods for detecting viruses such as CSFV (Conlan et al., 2009). The principle of this 
technology relies on immunomagnetic separation. The method involves coating of 
antigen specific antibodies on to small super-paramagnetic particles or beads. Both 
intact viruses and their soluble antigenic determinants can be detected after 
extraction from the test sample, using a secondary antibody in a sandwich format. As 
a solid surface-free binding method, the antigen-capture assays using 
immunomagnetic beads enhance the kinetics o f an antigen-antibody reaction and as a 
result, both non-specific binding and incubation times can be reduced (OIE, 
2008b).These antigen detection methods are particularly useful for viruses that grow
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slowly (CMV), or are labile (respiratory syncytial virus [RSV]), which makes their 
recovery in cell culture difficult.
Combining the high resolution of gel electrophoresis with the specificity of 
immunochemical detection, immunoblotting (also called Western blotting) offers the 
means for identification of immunodominant epitopes from infected animals. 
Immunoblotting is performed mainly to identify and/or to characterize infectious 
agents based on antigen specificity. Due to the high specificity and sensitivity achieved 
in this method, ambiguous and inconclusive results obtained in other diagnostic 
assays can often be resolved in this assay (Caballero et al., 1993). A modification of 
the technique (Scrapie-associated fibrils - Western blot) is used as a confirmatory test 
for bovine spongiform encephalopathy (BSE) detection (Beekes et al., 1995 ), and to 
differentiate between BSE and scrapie (Stack et al., 2002). Immunoblotting is also 
used to determine the specificity of individual monoclonal antibodies (mAbs). Purified 
antigenic polypeptides may be transferred to nitrocellulose membranes and assayed 
for the reactivity of mAbs to these proteins. A similar technique called 
immunochromatography provides a convenient method for detection of viruses 
without a need for special apparatus and laborious reaction setup. The 
immunochromatographic kits such as the one used for Influenza A and B (Michimaru 
et al., 2008) deliver rapid as well as accurate results within a short period.
The proteome is the total complement of proteins expressed within a cell, 
tissue, or organism, and proteomics is the study of the proteins including their 
expression levels, post-translational modifications and interactions with other 
proteins. Use of proteomics in the diagnosis of viral diseases is still in its infancy but 
may prove to be of considerable importance in the near future. For example.
definitive diagnosis of chronic hepatitis B virus (HBV) infection still relies on liver 
biopsy, but proteomic analysis of serum samples shows that expression of at least 
seven serum proteins is changed significantly in chronic HBV patients (He etal., 2003). 
Similarly, proteomics could aid in differential diagnosis of variant and sporadic forms 
of Creutzfeldt-Jacob disease (CJD) (Choe et al., 2002). An extremely useful application 
of proteomics to the diagnosis of infectious diseases is in the identification of novel 
diagnostic antigens by screening serum from infected and uninfected individuals (OIE, 
2008b).
1.1.3 Serology
Serological tests detect the footprints of a disease in the form of specific 
antibodies developed in response to the infecting virus. Serological tests are applied in 
the diagnosis of recent or chronic viral infections, in determining the immune status of 
an animal population for a specific virus, for surveillance and epidemiological studies, 
and to verify the immune response to vaccination (Zuckerman, 2009). In addition, 
serological detection of IgM and IgG in sera can differentiate current infections from 
previous infections. Prenatal antibody screening can provide useful information on the 
risk of contracting certain viral infections during pregnancy. In some situations 
identification of virus specific antibodies in the serum or other body fluids are the only 
choice for disease diagnosis of latent infections. There are occasions in which obtaining 
proper specimens for culture or for antigen detection assays is difficult. The Specimen 
might also have been collected too late in the course of disease for antigen detection. 
In all such cases serology proves to be an invaluable tool. Serological methods can 
assist in detection of viruses in blood during transfusion and from tissues during
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transplantations. Popular methods include antibody ELISA, complement fixation test 
(CFT), and virus neutralisation test (VNT), which can detect and measure the 
concentration of antibody in serum and serous fluids.
1.1.3.1 Antibody ELISA
Competitive-ELISA (C-ELISA) and indirect ELISA are two prominent techniques 
under the antibody ELISA. The principle of C-ELISA (Figure 1.2) is based on the 
competition between test serum, and a 'detecting antibody' (specifically added to  the 
reaction), to bind the standard antigen coated on the wells. Specific binding of the 
'detecting antibody' to the antigen is detected using an appropriate anti-species 
conjugate. A reduction in the expected colour obtained is due to binding of antibodies 
in the test serum to the standard antigen, which prevent binding of the detecting 
antibody (OIE, 2008b).
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Figure 1.2: Detection of rinderpest virus antibody with a C-ELISA technique (FAO, 
2010). The rinderpest antibody in the test sample binds the standard rinderpest 
antigen on the plate thereby inhibiting the anti-rinderpest antibody from binding the 
antigen. This is verified by the absence of colour following addition of anti-mouse HRP 
conjugate. Presence of the colour indicates a negative reaction.
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, In an indirect ELISA (Figure 1.3) the standard antigen specific to the antibody 
being detected is coated on to the wells. After application of the test serum the 
antibody, if present, would bind to the standard antigen. The antigen-antibody 
complex is detected by an enzyme-labelled secondary antibody that is targeted against 
the antibody in the test serum. If the test serum is positive for the antibody the 
secondary antibody would bind and produce colour upon addition of substrate.
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Figure 1.3: Detection of rubella virus antibody with an indirect ELISA technique
(Diaproph-Med, 2003). The rubella antibody from the test sample binds the 
immobilised standard rubella antigen on the plate. An anti rubella IgG monoclonal 
antibody that binds the test antibody is added to the reaction. Following addition of 
substrate, colour is produced indicating a positive reaction.
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In C-ELISA, samples from many species may be tested without the need for 
species-specific enzyme-labelled conjugates and the standard coating antigen need not 
be pure (OIE, 2008b). Purity is the key issue in indirect ELISA where crude and impure 
antigens result in high background. Due to these significant advantages C-ELISA over its 
counterpart, is favourably used for large-scale screening and sero-surveillance studies.
The C-ELISA format has been successfully used in the screening of large 
numbers of pig sera for CSFV antibodies (Wensvoort et al., 1988), and more recently it 
has been used for large-scale serological surveillance during the UK foot and mouth 
disease (FMD) outbreak in 2001 (Paiba et a!., 2004).
1.1.3.2 Complement fixation test (CFT)
The CFT (Figure 1.4) has the distinct advantage of accurately detecting 
significant rises in antibody levels during viral infections (Stark & Lewis, 1992) and 
hence it has been one of the widely used serological assays in clinical virology in the 
past. The procedure involves mixing heat inactivated test serum with specific viral 
antigen in presence of complement. Antibodies from the serum cross react with the 
antigen, and the complement in turn binds the antibody-antigen complex and gets 
depleted from the mixture. To detect the presence or absence of the complement, 
sheep red blood cells (RBC) coated with a standard concentration of specific antibody 
is applied to the mixture. The antibody coated RBCs activate unbound complement in 
the test serum and consequently result in RBC lysis. The absence of haemolysis 
indicates that specific antibody-antigen complex has formed, thereby binding and 
depleting the complement and preventing the lysis of RBCs.
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Figure 1.4: A schematic diagram to show the complement fixation test (DSHS, 2004). 
The CFT procedure involves mixing heat inactivated test serum with specific viral 
antigen in presence of complement. The complement binds antibody-antigen complex 
and depleted from the mixture. To detect the complement, sheep RBCs coated with a 
standard concentration of specific antibody is applied to the mixture. The antibody 
coated RBCs activate unbound complement (negative sample) in the test serum and 
consequently result in RBC lysis.
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The major disadvantage of the method is that it is technically demanding, 
requires rigid standardisation and titration of the reagents involved and, has a long 
turnaround time. Moreover, the CFT is less sensitive than other methods mainly due to 
anti-complementary activity, which occurs by non-specific binding of serum 
components to the complement in the assay. Use of CFT in viral diagnosis is being 
limited to virus research, to  detect viruses for which no other commercial tests are 
available.
1.1.3.3 Virus neutralisation test (VNT)
The VNT is based on the detection of virus-specific antibodies in serum by their 
ability to neutralize or block the infectivity and replication of a given virus in cell 
culture (Ballew, 1992). In VNT a standard concentration of a known viable virus is 
mixed and incubated with the test serum. Serial dilutions of the virus serum mixture 
are then made and inoculated onto the cells, which are susceptible to the virus being 
used in the assay. Cells are incubated at a suitable temperature for virus growth and 
examined for CPE, which usually occurs after 5-7 days post infection. If the test serum 
has neutralising antibodies that bind the virus, CPE will not be produced. Conversely, 
the absence of antibodies in the test serum results in the virus infection of cells and 
CPE. Serial dilutions of the test serum aid in quantifying the concentration of the 
antibody in the serum. VNT is time consuming, expensive, cumbersome and virus used 
in the system has to be quantified through careful titrations. However, VNT is 
applicable to all viruses that can be cultured and neutralisation of the virus with the 
antibody in the test serum has biological relevance as it signifies establishment of
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immunity to the infecting virus. Enteroviruses are usually detected by this method 
(Edwin & Thomas, 1999).
Since the 1970s recombinant DNA technology has boosted the use of 
serological techniques through provision of recombinant antigens (OIE, 2008b). 
Recombinant antigen proteins are expressed in E.coli (Pines & Inouye, 1999), yeast 
(Carter et ol., 1987), insect cells (Stewart & Possee, 1993) or eukaryotic cells (Smith et 
al., 1983). Recombinant proteins are of higher purity, specificity and possess batch-to- 
batch consistency over purified natural viral antigens as they are produced through 
laboratory grown genetically modified organisms. Synthetic peptides can also be used 
as antigens for viral laboratory diagnosis (OIE, 2008b). Synthetic peptides have 
advantages over recombinant antigens in being shorter compared to recombinant 
antigens and thus require a shorter processing time comparatively. Availability of viral 
gene sequences and advances in the development of PCR methodology have ensured 
that gene sequences from closely related species could be amplified and cloned in 
various expression systems, thus facilitating the development of serological detection 
techniques (Tortorella et al., 2000; Rappuoli & Covacci, 2003).
Proteomic multiplex immunoassays have provided a significant step towards 
multiplex antibody detection. However, the requirement for specialized high- 
throughput equipment has limited their application. Coupling the standard ELISA 
technique with luminex bead technology (Elshal & McCoy, 2006) has resulted in 
widespread use of antigen-coupled beads for monitoring antibodies in sera by flow 
cytometry (Jessica et al., 2009). This technology was further improved by producing 
antigens through in vitro transcription/translation methods instead of lengthy
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traditional expression systems. The test was successful in simultaneous detection of 
antibodies to Epstein-Barr virus nuclear protein 1, 3A and 3B (OIE, 2008b).
The major disadvantage of serological tests is that antibody response to 
infection can take over a week to develop and a rapid diagnosis is often needed before 
this time. Moreover, antibody-antigen cross reactions do occur in serological tests, 
leading to false positive results (Barbara et ol., 2006).
1.1.4 Electron microscopy (EM)
The role of EM in virus research was limited until the introduction of negative 
staining (Figure 1.5 A&B) in 1959 (Brenner & Horne, 1959). Negative staining has 
greatly simplified specimen preparation and staining procedures and reveals far 
greater structural details than the earlier staining techniques. EM as a diagnostic tool 
in the investigation of animal viruses gained prominence in the year 1960 during which 
smallpox virus was rapidly diagnosed and differentiated by pattern recognition 
(structural morphology), from a skin sample co-infected with herpesvirus (Long et al., 
1970). Subsequently, viruses such as HBV and parvovirus B19 were routinely diagnosed 
by EM. Norovirus (Kapikian et al., 1972), rotavirus (Flewett et al., 1973), adenoviruses 
(Flewett et al., 1975) and human astrovirus (Appleton & Higgins, 1975) were 
discovered using EM. EM has been the principle diagnostic method for routine 
detection of viruses associated with gastroenteritis until recently (Curry et al., 2006). 
Even though negative staining is rapid, it has its disadvantages; the pH of the negative 
stain might have a detrimental effect on the details seen and contrast produced in a 
specimen, especially in the case of double capsid shell viruses such as the group B 
rotavirus (Madeley, 1972). Negative staining is usually performed using
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phosphotungstic acid (PTA), but there are other stains such as ammonium molybdate/ 
uranyi acetate, sodium silicotungstate and methylamine tungstate (Curry et al., 2006) 
that can be used. PTA is the commonly used reagent in negative staining, however, 
viruses such as poxvirus need to be stained with uranyi acetate to reveal the best 
structural details. At least a minimum of 10  ^ -  10  ^ particles per millilitre must be 
present in the sample to allow detection by negative stain EM.
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Figure 1.5: Negatively stained monkeypox virus (A;) and herpesvirus (B;) under the
EM (Curry et al., 2006). The negative stain moulds around the virus particle and to a 
certain extent penetrates its crevices revealing both external as well as internal 
structural components of the viruses.
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Negative staining performed on thin tissue sections embedded into resin such 
as araldite epoxy (Figure 1.6) or acrylic, allows visualisation of virus replications in cells 
(Curry et al., 2006). This resin embedding and thin sectioning technique is used to 
detect viruses such as rotavirus B that are difficult to be visualized through standard 
negative staining. However, the technique is time consuming comparatively and hence 
is mostly limited to research studies.
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Figure 1.6: Negatively stained thin section of cuitured celis containing replicating 
adenovirus particles, prepared by resin embedding and thin sectioning technique, 
visualized under EM. Note the crystalline arrays of virus assembling within the cell 
nucleus (Curry et al., 2006).
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Immune electron microscopy (lEM) offers better sensitivity and virus 
identification compared to standard EM. lEM methods such as immune clumping, solid 
phase immune electron microscopy (SPIEM), and immuno-gold labelling (Curry et al., 
2006) have been applied for detection of viruses causing hepatitis (Almeida et al., 
1969; Feinstone et al., 1973; Balayan et al., 1983) and gastroenteritis. Both immune 
clumping and SPIEM are used routinely for virus detection whereas immuno-gold 
labelling is limited to research investigations (Curry et a i, 2006). The immune clumping 
method is used for visualisation of viruses such as HBV and parvovirus B19 (Figure 1.7) 
that lack distinctive morphological features and are thus difficult to be discerned from 
the background debris in the samples. In this method 'detector antibodies' that are 
specific to the virus under investigation are mixed into the sample. Target virus, if 
present in the sample, will be aggregated into clumps by the antibodies, thus allowing 
for easier detection. The immune clumping method can also be used for typing viruses 
such as enterovirus using type-specific antisera (Lee et a i, 1996).
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Figure 1.7: Negatively stained parvovirus B19 particles visualized under EM. The virus 
particles are aggregated into a clump by specific detector antibody (Curry et al., 2006).
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The SPIEM method makes use of grids to evenly disperse the virus particles that 
are trapped onto the grid by specific antibodies (Kenneth, 1973). The majority of the 
viruses detected by this method are those associated with gastroenteritis, particularly 
noroviruses, which are often present in small numbers making detection difficult by 
other methods (Wood & Bailey, 1987). Immuno-gold labelling method makes use of 
specific antibodies tagged with small particles of colloidal gold as an electron dense 
marker (Curry et al., 2006). This method is used for visualisation of viruses or viral 
antigens in cells or tissues. Sample preparation and processing in this method require 
highly specialized cryofixing techniques and hence is mostly limited to viral research.
Development of other techniques for viral diagnosis such as ELISA and, in 
particular, the advancements in the field of molecular based methods, such as the PCR, 
have contributed to the gradual decline in the use of EM (Curry et al., 2006). However, 
EM is still regarded as one of the popular methods for virus detection and discovery. 
Viruses such as Hendra virus (Murray et al., 1995) and Nipha virus (Chua et al., 1999) 
were discovered by EM. Severe acute respiratory syndrome (SARS) was first discovered 
in 2003 by negative stain EM in China and Hong Kong (Falsey & Walsh, 2003; Ksiazek et 
al., 2003). The virus showed characteristic morphology of a coronavirus. One of the 
advantages of the EM is that it can be used to detect multiple viral agents in a sample. 
Many viruses responsible for gastrointestinal infections contain an RNA genome that is 
susceptible to mutations, which may alter the genome and phenotypic structure thus 
rendering antigen, antibody and nucleic acid detection techniques obsolete (Curry et 
al., 2006). In such cases EM could be a valuable tool for viral diagnosis.
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1.1.5 Nucleic acid detection
Detection of viral nucleic acid is an alternative to the other methods of 
laboratory diagnosis and it does not rely upon the ability of the viruses to replicate in 
tissue culture. Molecular biology has contributed tremendously to the development of 
various detection techniques that target specific viral nucleic acids. PCR, which was 
first developed in 1985 (Saiki et al., 1985), takes advantage of natural DNA replication 
methodology and results in the in vitro production of large quantities of desired DNA 
sequences from a complex mixture of heterogeneous sequences (Saiki et al., 1988). 
PCR can amplify selected regions of 50 to several thousand base pairs (OIE, 2008b) and 
the amplification is achieved through a cyclic succession of incubation steps at 
different temperatures. Initially, the double stranded target DNA is heat denatured to 
form single stranded templates. Short synthetic molecules of DNA, primers, which are 
complementary to both strands and flanking the target sequences are annealed to the 
single-stranded template at low temperature and extended with DNA polymerase at 
an intermediate temperature. The synthesized new strand is separated from the 
template by heating to a higher temperature and work as templates for synthesis of 
more strands. The cycling steps are repeated 20-40 times resulting in amplification of 
target DNA sequence. To detect RNA, complementary DNA (cDNA) is first synthesized 
by reverse transcriptase enzyme (RT) and the cDNA acts as the template for 
amplification in the PCR. Amplified products generated by PCR are separated according 
to their size by gel electrophoresis, stained and visualized by UV. Amplified products 
are often sequenced to confirm the nature of the PCR products and also for 
phylogenetic studies. Analysis of PCR products at the nucleotide level has facilitated 
the epidemiological studies of infectious disease outbreaks, and helped to  monitor the
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treatment outcomes for infections, in particular with viruses that mutate at higher 
frequency. Viruses such as influenza A are detected and further characterized to  
determine their pathogenicity, utilising RT-PCR (Horimoto et al., 1995). Multiplexing a 
standard PCR permits simultaneous detection of more than one virus or even a virus 
and a different class of pathogen e.g. EBV and Toxoplasma gondii from brain of 
patients infects with HIV virus. The sensitivity of the standard PCR can be enhanced by 
incorporating a second set of primers to amplify a sub-fragment from the PCR product 
of the first reaction. This technique, nested-PCR, however can increase false positive 
results (OIE, 2008b) unless strict measures are taken to prevent cross contamination. 
Degenerate PCR that employs primers incorporated with universal nucleotide bases 
instead of sequence specific bases is also in routine use in viral diagnosis. Viruses such 
as herpes simplex virus and varicella zoster virus are often detected with degenerate 
PCR (Jacobs et al., 1999).
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Figure 1.8: A diagram to iiiustrate the cycling steps in a standard PCR
{Virtualmedicaicentre, 2008).
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Enhancements in the field of PCR analysis led to the development of real-time 
PCR (Higuchi et al., 1992; Higuchi et al., 1993). Real-time PCR refers to amplification of 
DNA that is monitored at each step of the reaction process. The benefit is that it has 
the ability to confirm the amplification products in real time and to quantitate the 
target concentration. Present day real-time PCR technology however, is based mostly 
on hydrolysis probes (TaqMan probes), although dyes such as SYBR green I, BEBO, 
YOYO-1, and TOTO-1 are also used (Valasek & Repa, 2005). TaqMan probe, which is a 
short stretch of oligonucleotide complementary to a specific region on the template, is 
dual fluorophore labeled. It has one fluorophore at the 5' end (reporter) and one at 
the 3' end (quencher). When the reporter and quencher are in close proximity, that is, 
attached to the probe, the quencher absorbs the energy from the reporter, thus 
stopping the reporter fluorescing. In the amplification process, the DNA polymerase 5' 
exonuclease activity breaks the oligonucleotide probe effectively separating the 
reporter from quencher and this allows the fluorescence energy of the reporter to be 
liberated. Thus, the hydrolysis of the probe results in increase of the. signal and 
corresponds with the specific amplification of the DNA. Examples of common 
quencher and reporter fluorophores include TAMARA, DABCYL, BHQ, and FAM, HEX, 
ROX, CY5 respectively. Other variations of the quencher-reporter theme that are often 
used include hybridisation probes, molecular beacons, sunrise primers, and scorpion 
primers. An advanced version of real-time PCR, called the real-time multiplex PCR 
(Wittwer et al., 2001) that uses multiple probes labeled with different reporter and 
quencher combinations are also being employed. Since the melting temperature (Tm) 
and emission spectra of each probe are unique, multiplexing of PCR by incorporating 
multiple primers and probe sets can achieve simultaneous detection of multiple
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viruses. New fluorescent chemistries that are focused on increasing sensitivity and 
specificity, enhancing multiplex capabilities, and reducing the cost, are continually 
being developed. Real-time PCR has a wide dynamic range of up to 10^-fold (compared 
to 1000-fold in a standard PCR) due to the increased sensitivity of the fluorescent 
detection system (Ratcliff et al., 2007).
PCR is being routinely employed in diagnostic settings, often using generic, 
degenerate primers or in a multiplex format. However, the PCR has also suffered from 
drawbacks like other detection techniques. Inhibitors like haemoglobin, urea, 
lactoferrin and bile salts which are often found in clinical samples, along with added 
preservatives such as EDTA, heparin and formalin, can reduce the efficiency of, or 
inhibit, the RT and DNA polymerases in a PCR reaction, leading to false negative results 
(Valasek & Repa, 2005). RNA, compared to DNA, is extremely labile and is prone to 
degradation by nucleases. Moreover, the RT enzyme used to synthesize cDNA from 
RNA is not efficient and is error prone. Primer and probe specificity is a key issue that 
affects PCR. Mismatches of even two bases at the 3' end of a primer can reduce the 
detection limit by 3 logs (Whiley & Sloots, 2005). Degenerate primers, designed to 
detect virus strains that show considerable diversity such as herpesvirus (Griffiths, 
2005), are less sensitive and pose problems during sequencing. RNA viruses such as 
HIV, apart from exhibiting high sequence variability amongst their divergent strains, 
are highly prone to mutation and recombination, thus creating the likelihood of primer 
and probe mismatches. PCR performed on clinical samples from a disease-affected 
animal, cannot differentiate between viable and non-viable viruses, hence it is difficult 
to ascertain the state of infection, that is, distinguish between acute and latent 
infection.
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Techniques such as restriction fragment length polymorphism (RFLP) (Figure 
1.9) and ligase chain reaction (LCR) (Figure 1.10) facilitate the differentiation between 
closely related viruses. The approach is based on the fact that genomes of even closely 
related viruses are defined by variation in sequence. RFLP works on the principle that a 
linear order of adjacent nucleotides comprising the recognition sequences of a specific 
restriction enzyme in one genome may be absent in the genome of a closely related 
strain or isolate. In RFLP, the nucleic acids of the viruses under study are extracted and 
digested with a specific panel of restriction enzymes. The individual fragments are 
separated according to their sizes and examined via gel electrophoresis. Each virus is 
then identified according to its unique pattern (fingerprint). A good example on 
application of RFLP is the analysis of rabies virus biotypes from dog and vampire bats 
from Latin America (Loza et al., 1999). Incorporation of polyacrylamide gel 
electrophoresis (PAGE) in the RFLP facilitates separation of larger fragments (up to 
megabase size) (Jager et al., 1998).
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Figure 1.9: A diagram to illustrate restriction fragment length polymorphism (Daniel, 
2000). The DNA sample is digested with one or multiple restriction enzymes and 
resolved in to bands of varying sizes based on molecular weight, on an electrophoresis 
gel. Using Southern blot method the separated bands are transferred on to a 
nitrocellulose membrane, and identified using complementary labelled probes.
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The LCR makes use of a thermostable ligase and allows the discrimination of 
DNA sequences differing in only a single base pair (Wiedmann et ol., 1994). In LCR the 
DNA template is denatured and DNA ligase along with four synthetic oligonucleotide 
primers; two adjacent oligonucleotide primers, which uniquely hybridize to one strand 
of target DNA, and a complementary set of adjacent primers, which hybridize to the 
opposite strand, are added. The junction of the two primers is usually positioned so 
that the nucleotide at the 3' end of the upstream primer coincides with a potential 
single base-pair difference in the targeted sequence. Ifthq  two bases match, the DNA 
ligase will covalently link each set of primers. Both the ligated primers can now serve 
as template in the cyclic reaction leading to exponential amplification process. If there 
is a mismatch at the 3'end of two complementary up stream primers, the amplification 
will not proceed. LCR is more sensitive than PCR (Wiedmann et a i, 1994).
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Figure 1.10: An illustrative picture describing ail the steps in ligase chain reaction
(Nickerson et al., 2001). The highlighted nucleotide base pair in the double stranded 
target DNA is detected by 2 sets of primers. The primer set to the left containing the 
exact complementary base match hybridises the target and is amplified exponentially. 
The primer set to the right due to the mismatch doses not hybridise to the target, thus 
is not amplified. The amplified primer set is detected by gel electrophoresis.
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1.1.6 DNA Microarrays
Microarray technology is a high throughput technology consisting of an arrayed 
series of thousands of microscopic spots called features (Figure 1.11). These features 
are comprised of picomoles of specific DNA oligonucleotides, probes, which are 
immobilised on a platform and hybridize to the labelled target in the sample under 
optimized conditions. The probe-target hybridisation can be detected and quantified 
by fluorescence emitted by the fluorophore-, silver-, or chemiluminescence-labelled 
targets. The fluorescence is captured by a scanner and the data analysed using 
bioinformatic software. The platform on which the probes are immobilized can be solid 
such as glass (Agilent Technologies, US), silicon polymer (Affymetrix, US), or can be 
microscopic beads (Illumina, US) (Figure 1.12).
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Figure 1.11: An example of a spotted array on a glass slide. Inset shows an enlarged 
sub-array (Paphrag, 2006).
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Figure 1.12A: A glass array chip (Agilent Technologies, 2007).
GcmeCHip
Figure 1.12B: A silicon array chip (Singer, 2001).
Figure 1.12C: Microarray on beads (Yale, 2008).
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The microarray probes are covalently bound to the solid support via a chemical 
matrix such as epoxy-silane, amino-silane, lysine, or polyacrylamide. Microarray probes 
can be generated via in situ synthesis or pre-synthesized as synthetic oligonucleotides 
and spotted. The in situ synthesis produces very unique feature uniformity and is the 
preferred platform by most of the commercial companies worldwide. Probe formats of 
25mer (Affymetrix), and 60mer (Agilent Technologies) are commonly used in in situ 
synthesis. The 25mer probes are highly specific and the specificity decreases with the 
increase in probe size. Probes of 60 and 70 bases can accommodate up to 10 % 
nucleotide mismatch and hence can hybridize to divergent gene sequences (Palacios et 
al., 2007). DNA extracted from test materials has to be amplified in almost all 
diagnostic microarrays in order to achieve a satisfactory level o f sensitivity. The 
unknown nature of pathogens in clinical materials, especially those in clinical 
syndromes and in unknown disease outbreaks, dictates the use of sequence 
independent primers in the amplification steps.
Target labelling in the microarray can be direct or indirect. Direct labelling 
involves PCR incorporating fluorescent dye (Cy3 or Cy5) labelled deoxynucleotide 
triphosphates (dNTP) into the amplified target. Indirect labelling employs amino-allyl 
nucleotides in the PCR followed by dye coupling to  the integrated labelled nucleotides. 
Dyes such as Alexa flour 555, 647, Cy3 and Cy5 are widely used in indirect labelling of 
the target.
Microarray was initially performed on nylon membranes for eukaryotic gene 
expression profiling, but its scope was limited by the nature of the matrix used. With 
the availability of solid supports such as glass and silicon, microarray has become a 
popular tool in single nucleotide polymorphism (SNP) detection and analysis,
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quantitative analysis of gene expression, cancer research, and drug discovery (Heller, 
2002).
Apart from glass and silicon array formats, beaded arrays are also slowly 
gaining popularity in the field of virus diagnosis (LeBlanc et al., 2010). In beaded arrays 
such as BeadChip (Illumina) (Fan et a!., 2006), the oligonucleotides are synthesized on 
microscopic silicon beads. The beads are then randomly deposited into the wells on a 
substrate, such as a glass slide. The resultant array is decoded to determine which 
oligonucleotide-bead combination is in which well. The advantage of the beaded 
arrays is that very high levels of miniaturisation through high-density bead packaging 
can be achieved. Another array system that is miniature, and has the ability to analyze 
small volumes (micro, nano or even picoliters) of sample is the microfluidics 
microarray (Figure 1.13) (Situma et a!., 2006). The array platform comprises of 
miniature glass, silicon or polymer structures composed of an ultra microscopic fluidic 
network of channels (as small as 100 nm in diameter) in a closed architectural 
framework. The DNA probes are printed or synthesised In situ in these channels. The 
microfluidics arrays offer the potential for parallel processing of multiple samples and 
as each sample is loaded into separate channels, the chances of cross contamination 
are minimal. The method however, is very expensive and the whole process is not cost 
effective.
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Figure 1.13: A microfluidics chip (Nathan, 2007).
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1.1.7 Current literature on use of DNA microarrays for detection of viral 
pathogens
Over the last decade, microarray has carved a unique niche as a prominent 
diagnostic tool in clinical virology, especially in resolution of diseases with unknown 
aetiology or disease syndromes.
Signs and symptoms of viral diseases are rarely pathognomonic of a single viral 
agent, in particular, early in the course of the disease. This, in turn, demands 
employment of multiplex assays such as DNA microarrays in which many virus 
candidates can be tested at one time. The ability of the DNA microarrays to 
comprehensively detect known and novel viruses in a single assay makes it an 
appealing choice for surveillance, detection, and discovery programs.
The Virochip" developed by Wang and colleagues (2003) has proven to be extremely 
successful in both human and veterinary clinical settings. A recent example includes 
the successful identification of a novel coronavirus from a beluga whale held in an 
aquatic containment facility by the Virochip (Mihindukulasuriya et al., 2008). Other 
examples in the use of Virochip' include detection of a novel SARS coronavirus in 
severe acute respiratory syndromes (Ksiazek et a!., 2003), novel genotypes of corona 
and rhinoviruses in human respiratory tract infections (Kistler et a!., 2007) and a novel 
gammaretrovirus in prostate tumour (Urisman et a!., 2006).
The Virochip,' has also been successfully employed to detect known viruses 
from clinical syndromes. Examples of such use include detection of several porcine 
viruses, porcine reproductive and respiratory syndrome virus (PRRSV), porcine 
circovirus 2 (PCV2), influenza A virus and porcine respiratory coronavirus (PRCV) which
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often present similar clinical manifestations (Nicholson etal., 2011). Other similar DNA 
microarrays have also been developed which can detect and differentiate viruses 
causing vesicular or vesicular-like lesions in livestock animals (Philippa et oL, 2009) and 
strains of herpesviruses and adenoviruses in immunocompromised patients (Muller et 
a!., 2009). Besides panviral chips, microarray chips targeted a particular virus are also 
in use. Custom made diagnostic chips such as M chip (Dawson et a!., 2006), FluChip-55 
(Townsend etol., 2006) and TessArray RPM- Flu 3.0 & 3.1 can detect prominent strains 
of influenza A virus. DNA microarrays have also been employed to simultaneously 
detect and type known viruses e.g. detection and typing of 12 genotypes of human 
papillomaviruses (Brandstetter et o/., 2010).
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1.2 Background to the PhD project and objectives
This PhD project was funded as part of the BioChip project by the Department 
of Environment Food and Rural Affairs (Defra) which was awarded to a consortium of 7 
institutes; Animal Flealth and Veterinary Laboratories Agency (AFIVLA, Weybridge), 
Institute of Animal Flealth (lAFI, Pirbright), Food and Environment Research Agency 
(Fera), Institute of Animal Flealth (lAFI, Compton), Centre for Environment, Fisheries 
and Aquaculture Science (Cefas, UK), The Royal Veterinary College (RVC), and Flealth 
Protection Agency (FIPA). The overall aim of the BioChip project was to develop and 
validate, where possible, a generic microarray platform and series of protocols for the 
identification and characterisation of the major notifiable viruses and investigation of 
diseases of unknown aetiology. Two candidate groups of viruses specifically considered 
for this project were the zoonotic lyssaviruses and the notifiable CSF viruses. As part of 
this PhD project, a mini DNA microarray and associated protocols were designed to 
achieve a typing resolution at detection for these groups of viruses. Currently, there 
are 7 genotypes for lyssaviruses and 10 sub-genotypes for CSF viruses. A larger 
microarray (BioChip versions 3.1 and 4.1) developed by the consortium was applied to 
investigate several diseases of unknown aetiology in terrestrial animals.
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1.3 Lyssaviruses
Lyssaviruses (Greek: /ysso=madness) cause rabies [latin: rabere (to rage)] in all 
the animals grouped under the class Mammalia (Nel & Markotter, 2007). The genus 
Lyssavlrus is one of the six genera in the family Rhabdovlrldae [Greek: Rhabdos (rod)], 
a family of elongated bullet-shaped viruses classified under the order 
Mononegavlrales. This order houses all the known single-stranded, negative-sense, 
non-segmented RNA viruses. Different members of the family Rhabdovlrldae share 
similar morphological structures and replication mechanisms, and infect a wide range 
of hosts varying from mammals, birds, fish, plants, arthropods and some other 
invertebrates (Tordo et al., 2005). The genus Lyssavlrus includes classical rabies virus 
(RABV, genotype 1), Lagos bat virus (LBV, genotype 2), Mokola virus (MOKV, genotype 
3), Duvenhage virus (DUVV, genotype 4), European bat lyssavirus type 1 (EBLV 1, 
genotype 5), EBLV type 2 (genotype 6) and Australian bat lyssavirus (ABLV, genotype 
7). Recently, four new lyssaviruses Aravan virus, Khujand virus, Irkut virus and West- 
Caucasian bat virus (WCBV) were isolated, but they are yet to be characterized 
according to genotype (Kuzmin et al., 2003; Kuzmin et al., 2005). All the lyssaviruses 
can be divided into two or possibly three phylogroups based on nucleotide sequence 
and immunogenicity (Fooks, 2004; Barbara et al., 2006). Genotype 1, 4, 5, 6 and 7, 
Aravan virus, Khujand virus and Irkut virus comprises phylogroup I, whilst phylogroup II 
contains genotypes 2, 3 and the most divergent WCBV.
RABV is found distributed in almost all the parts of the world except in 
Australia, Antarctica, parts of Scandinavia, UK and few Western European countries 
and islands (Nel & Markotter, 2007). Canine species such as foxes, skunks, racoons.
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jackals, and bats harbour RABV. To date, RABV in bats has been found only in the 
Americas. The LBV, MOKV and DUVV are found only in Africa. Frugivorous bats such as 
Eidolon, Epomophorous and Roussetus harbour LBV. LBV is the only virus in the genus, 
which is not zoonotic, although it has been isolated from a few terrestrial mammals. 
MOKV has no specific reservoir and to date it has been isolated only from terrestrial 
mammals. DUVV is harboured in insectivorous bats such as Mlnlopterus and Nycterls 
species. EBLV-1 & EBLV-2 are found in Europe only. In the UK all the rabies virus 
infections recorded to date were caused by EBLV-2 (Smith et oL, 2005). EBLV-1 has 
never been identified in the UK. Insectivorous bats such as Epteslcus species (common 
Serotine) and Myotls species (Daubenton's myotis) harbour EBLV-1 and EBLV-2, 
respectively. EBLV-1 and -2  have been subdivided in to two phylogenetic lineages, 
EBLV-la & la , and EBLV- 2a& 2b respectively (Amengual et al., 1997). ABLV is found 
only in Australia (Nel & Markotter, 2007). Frugivorous bats such as Pteropus species 
and various insectivorous bats such as Saccolalmus flavlventrls harbour ABLV. Aravan 
virus and Khujand virus are found only in Central Asia. Insectivorous bats Myotls blythll 
and Myotls mystaclnus harbour Aravan and Khujand viruses respectively. Irkut virus is 
found in Eastern Siberia only. Insectivorous bat Murlna leucogaster harbours the virus. 
WCBV is specific to Caucasian region and is harboured by Insectivorous bat 
Mlnlopterus schrelbersll.
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Figure 1.14: Worldwide distribution of Rabies (Martin, 2009).
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1.3.1 Virus structure & genome
The type species of the genus Lyssavirus, the RABV is a bullet shaped, 
enveloped virus measuring about 180 nm in length and 75 nm in width (Nel & 
Markotter, 2007). Variations in length (100-300 nm) observed in the size of the virus 
particle may be due to strain differences, or defective interfering particles (Dl) with 
truncated genomes (Holland, 1987). Genome of RABV is 12 KB in length and encodes 5 
viral proteins (3' to 5'); nucleoprotein (N), phosphoprotein (P), matrix protein (M), 
glycoprotein (G), and RNA-dependent RNA polymerase (L) proteins (Figure 1.16). The 
bullet shaped particle with glycoprotein spikes and coiled ribonucleoprotein complex 
can be seen in the Figure 1.15.
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Figure 1.15: Structure of rabies virus (Erica et al., 2001). The virus is a bullet shaped, 
enveloped virus measuring about 180 nm in length and 75 nm in width.
{-) strand RNA genome
p c HI 3— 5'
Figure 1.16: Genomic organisation of rabies virus (SIB, 2010). Single-stranded negative 
sense RNA genome of rabies virus showing location of genes for nucleoprotein (N), 
phosphoprotein (P), matrix protein (M), glycoprotein (G) and RNA-dependent RNA 
polymerase proteins (L).
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The RNA genome along with P, N and L proteins form the helical nucleocapsid. 
A lipoproteinaceous envelope that is derived from the host cell membrane during virus 
budding surrounds the nucleocapsid. The envelope has numerous G protein spikes 
protruding from the surface and these are anchored by a 22 amino acid (aa) 
hydrophobic transmembrane domain. The G protein, which forms trimers (Gaudin et 
al., 1992), and contains receptor-binding domains for attachment to the host cells 
(Thoulouze et al., 1998), plays a major role in viral pathogenesis (Dietzschold et al., 
1983; Prehaud et al., 1988). The M protein forms a layer between the envelope and 
the nucleocapsid, and is responsible for virus budding and the characteristic bullet 
shape of the virion (Mebatsion et al., 1999). The nucleotide and the deduced aa 
sequence comparison of all the protein coding genes amongst the viruses within the 
genus Lyssavirus shows that the degree of conservation varies in the order: N> L> M> 
G> P (Bourhy et al., 1993). The N gene although highly conserved, allows adequate 
differentiation among the viruses in the genus (Johnson et al., 2002). The present 
classification of all the viruses in the genus Lyssavirus in to seven genotypes is based 
on the N gene (Bourhy et al., 1992; Bourhy et al., 1993). This has been further 
confirmed by the recent studies on the analysis of G (Badrane & Tordo, 2001) and P 
genes and their deduced amino acids (Nadin-Davis et o/,, 2001).
1.3.2 Disease pathogenesis
Rabies is a zoonotic, acute encephalomyelitis, the symptoms of which include a 
variety of neurological disorders brought about by viral interference in the central 
nervous system (CNS) (Jackson, 2002). Rabies is one of the few diseases that has been 
reported in the old world before 2300 BC (Steel & Fernandez, 1991). The absence of
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effective control measures in the animal reservoir population, combined with a 
widespread lack of human access to pre and post prophylactic measures, means that 
more than 50,000 people annually die of rabies virus infections, particularly in Asia and 
Africa (Warrell & Warrell, 2004; Knobel et al., 2005). Globally rabies is most commonly 
caused by RABV although all the other viruses in the genus Lyssavirus cause rabies 
infections, which are clinically indistinguishable. Infection occurs by inoculation of the 
virus into a bite wound through the saliva of an infected animal (Madhusudana, 2005). 
The receptors of the rabies virus include nicotinic acetylcholine receptors, neural cell 
adhesion molecules (NCAM), and nerve growth factor receptors. Upon entry the virus 
initially multiplies in the local musculature at the site of the bite, and then spreads 
through motor or sensory neurons to the spinal cord and brain. Once the virus reaches 
the brain, there is extensive replication involving every region. Later, the virus through 
centrifugal spread via nerves, reaches the non-neural organs such as salivary glands, 
skin, liver, and heart. Despite wide spread replication, there are not many pathological 
changes in the brain apart from Negri bodies (eosinophilic pathognomonic inclusions) 
(Watson, 1913). External factors that could contribute to the disease process include 
neuronal apoptosis, abnormalities in the neurotransmitters, and accumulation of nitric 
oxide and pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-a) 
(Jackson, 2002). After a prolonged and a variable incubation period that ranges from a 
few days to a few years, rabies manifests itself in two forms; the more common 
encephalitic form (also called furious rabies) with classical clinical manifestations like 
hydrophobia, aerophobia and aggressive behaviour, and the less common paralytic 
rabies (dumb rabies). Laboratory confirmation may not be needed with the furious 
form but is particularly needed to  diagnose the dumb form of rabies.
49
Rabies virus evolution through selective immune pressure and adaptation has 
led to the effective dissemination o f virus into new host species (Fooks, 2004). 
Furthermore, illegal importation of bats and wildlife has led to spread of infections into 
disease free areas. The present genotypes in the genus Lyssavirus are so divergent that 
scientists predict the existence of other unidentified intermediate genotypes, in wild 
mammalian populations. Hence, the need for a diagnostic tool that can identify 
divergent viral genotypes apart from efficient routine diagnosis of present known 
genotypes is essential. Moreover, the identification of unknown genotypes would also 
aid in the preparation of antiviral drugs and vaccines to counter any unprecedented 
attacks.
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1.4 Classical swine fever viruses
CSFV, the causative agent of classical swine fever (CSF) is an enveloped, single -  
stranded, positive-sense RNA virus classified in the genus Pestivirus, under the family 
Flaviviridae (Paton & Greiser-Wilke, 2003). The genus Pestivirus, along with CSFV, is 
comprised of 3 other recognized species Bovine viral diarrhoea virus genotype 1 
(BVDV-1), Bovine viral diarrhoea virus genotype 2 (BVDV-2), and Border disease virus 
(BDV) (Regenmortel et al., 2000). A fifth tentative species is represented by the strain 
H138, isolated from a giraffe in Kenya (Plowright, 1969). CSFV causes CSF in pigs and 
wild boars (Paton & Greiser-Wilke, 2003). BVDV-1 and 2 causes bovine viral diarrhoea 
in cattle, pigs (Wang, 1996), and other domestic and wild animals, including deer 
(Becher et al., 1999). BDV causes border disease in sheep and cattle (Cranwell et al., 
2007). Besides the established species, there are three groups of recently identified 
but unclassified pestiviruses (Lihong et al., 2009). The first group, also called "atypical" 
pestiviruses, is comprised of four closely related species; D32/00_'HoBi' (Schirrmeier et 
al., 2004), Brz buf 9 (Stalder et al., 2005), CH-KaFlo/cont (Stalder et al., 2005), and 
Th/04_Khon-Kaen (Stahl et a i, 2007) that were isolated from cattle. The second group 
consists of two divergent, non-bovine pestiviruses; Bungowannah virus isolated from 
pigs associated with porcine myocarditis syndrome in Australia (Kirkland et a i, 2007), 
and another un-named novel virus isolated from a diseased young blind pronghorn 
antelope from USA (Vilcek et a i, 2005). The third group, "Tunisian isolates", comprises 
of novel viruses that were isolated from Tunisian sheep (Thabti et a i, 2005).
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1.4.1 Virus structure and genome
CSFV virions are hexagonally shaped particles, and have an electron-dense 
inner core of about 30 nm, surrounded by a spherical envelope with diameter ranging 
between 40 and 60 nm (Wengler et al., 1995). Glycosylated membrane proteins cover 
the envelope. Underneath the envelope lies the icosahedral shaped nucleocapsid. The 
genome is 12.3 kb in length (Meyers et al., 1989; Moormann et al., 1996; Ruggli et al., 
1996) and contains two untranslated regions (UTRs) at the 5' and 3' ends, and an open 
reading frame (ORF) encoding a polyprotein (Lihong et a i, 2009). The polyprotein is co- 
and post-translationally cleaved into 12 polypeptides in the order; N-terminal 
autoprotease (N "^^ °), capsid protein (C), envelop proteins (E El, and E2), P7, and 
non-structural (NS) proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B) (Thiel et a i, 
1996). The two diagnostically prominent nucleotide sequences, the 5'UTR, and the E2 
(coding for the major envelope glycoprotein E2), present towards the 5'end and 3'end 
of the genome respectively, are used in phylogenetic analysis (Figure 1.17) (Paton et 
a i, 2000). A 150 bases nucleotide stretch of the 5'UTR sequence that spans nucleotide 
200-349 on the reference strain Alfort 187 (accession number X87939), is the most 
conserved region amongst all the CSFV strains, in contrast to a 190 nucleotide (2518- 
2707) stretch within E2 which is the most diverse. Phylogenetic analysis of the 190 bp 
E2 region differentiates all the CSFV strains into 3 major genotypes, genotypes 1, 2 and 
3 (Paton et a i, 2000). Genotypes 1 and 2 are further subdivided into 3 sub-genotypes, 
1.1,1.2,1.3, and 2.1, 2.2, 2.3 respectively. Genotype 3 is divided into 4 sub-genotypes, 
3.1, 3.2, 3.3 and 3.4. Genotype 1 causes sporadic outbreaks in certain parts of Eastern 
Europe, Russia, Central America, China, and Thailand (Paton & Greiser-Wilke, 2003;
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Sarma et al., 2009). Genotype 2 is currently prevalent in Eastern Europe and parts of 
Central Europe, and China. Genotype 3 is confined to Korea, Thailand, and Taiwan.
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Figure 1.17: Genome of CSFV showing the tw o regions 5' untransiated region and E2 
major glycoprotein region used in phylogenetic analysis (Paton et a!., 2000).
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1.4.2 Disease pathogenesis
CSF, also called hog cholera, is a contagious febrile disease of swine that has a 
potential for rapid spread (Greiser-Wilke et al., 2007). Major epidemics include the 
1997-98 Netherlands outbreak, which resulted in the loss of $2 billion (US) (Terpstra & 
de Smit, 2000). Due to the huge socio-economic impact the disease can have on the 
international swine industry, CSF is listed under the OIE list A of notifiable diseases 
(OIE, 2010). The major route of infection is oronasal transmission by direct or indirect 
contact with infected pigs, or through feed that is contaminated with virus (Moennig et 
al., 2003). Disease transmission via semen from infected boars may also occur (Floegel 
et al., 2000). The role of people, wild animals, and inanimate objects in disease 
transmission is also hypothesised (Dewulf et al., 2001; Elbers et al., 2001b; Elbers, 
2001), however, their exact role in virus spread is poorly defined. The incubation 
period in individual animals is about one week to 10 days (Floegel et al., 2000). 
FI owe ver, under field conditions in a holding, it would take at least 2-4 weeks or 
sometimes even longer for clinical signs to become evident. This shows that the there 
might be a long critical phase between virus introduction and detection of the 
outbreak, especially in densely populated areas (Engel et al., 2005b). CSFV is very 
invasive in vitro and previous research showed that the viral N protein aids in 
avoiding the antiviral effect of type I interferon, and prevents cell apoptosis (Ruggli et 
al., 2009). The severity of the clinical signs depends on the virulence of the strain, and 
the age, breed and immune status of the host animal (Floegel et al., 2003). In older 
animals the course of infection is often mild or sub-clinical. There are three forms of 
disease symptoms that are reported in pigs, acute, chronic and prenatal forms. The 
Acute form of infection is usually displayed in younger pigs of up to 12 weeks of age.
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Clinical signs include pyrexia (usually higher than 40 °C), enlarged and discoloured 
lymph nodes, respiratory signs, and constipation followed by diarrhoea. Neurological 
signs such as un-coordinated movements and convulsions are also frequently 
observed. Tell tale haemorrhagic signs in the skin are usually observed on the ear, tail, 
abdomen, and the inner side of the limbs during the second and third week after 
infection, until death. Viral replication in monocytes and macrophages induces the 
release of prostaglandins-E2, and interlukin-1 that play a role in inducing 
haemorrhages (Knoetig et al., 1999). The virus is shed from the infected animal by 
saliva, urine and faeces (Depner et al., 1994; Laevens et al., 1999). Gross pathological 
lesions visible on post mortem examination include swollen, oedematous and 
haemorrhagic lymph nodes and haemorrhagic lesions on the kidneys varying from 
petechiae to ecchymotic haemorrhages.
The chronic form of CSF is observed when pigs cannot mount an effective 
immune response against the infection. The chronic form in pigs is always fatal. The 
clinical symptoms observed in the chronic form are similar to the acute form of 
infection. Prenatal infection occurs if the virus infects the foetus (Depner et al., 1994; 
Laevens et al., 1999). Although CSFV infection in sows is often subclinical, the virus can 
cross the placenta and infect the foetus during any stage of pregnancy. Depending on 
the time of gestation and the virulence of the infecting virus, the piglets may be 
stillborn, or remain persistently infected. Infection during early stages of pregnancy 
may result in abortions, mummifications and malformations. Infection during the later 
stages of pregnancy (50-70 days) can lead to  birth of persistently viraemic piglets. 
These piglets may appear normal at birth but show late onset disease signs in the form
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of poor growth, wasting, or occasional congenital tremor. These pigs shed large 
amounts of virus and are considered as reservoirs of CSFV (Oirschot & Terpstra, 1977).
Most often hemorrhagic lesions caused by other enteric and respiratory 
infections in pigs can mask or overlap the most typical lesions of CSF. Such cases could 
mislead a presumptive diagnosis basing on the clinical signs (Depner et al., 1999). 
Moreover, the disease signs of other viral diseases such as African swine fever, porcine 
reproductive and respiratory syndrome (PRRS), and porcine multisystemic wasting 
syndrome (PMWS) create the same clinical and pathological picture like CSF. Hence 
laboratory diagnosis is utmost important to prevent false positive or negative cases.
1.5 Aims of this PhD project
The first aim of this PhD project was to design a mini DNA microarray in order 
to simultaneously detect and genotype the zoonotic lyssaviruses and the quarantine 
CSF viruses. A mini DNA microarray, LP (Lyssa-Pesti) chip, encompassing genotyping 
probes to lyssa and CSF viruses was developed and assessed to achieve this objective.
The second aim of the project was to apply the pan viral microarray (BioChip 
versions 3.1 and 4.1), developed as part of the BioChip consortium, to investigate 
clinical diseases or syndromes of unresolved aetiology. To achieve the second aim, the 
validated LP chip was incorporated into the BioChip versions 3.1 (Figure 1.18) and the 
chip, version 4.1, (Figure 1.19) was used for investigation of the unknown diseases.
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Figure 1.18: Percentage distribution of the probes in the BioChip version 3.1.
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Figure 1.19: Percentage distribution of the probes in the BioChip version 4.1.
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Chapter 2:
Development of a genotyping microarray for
lyssaviruses
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2.1 Introduction
Lyssavirus diagnosis is commonly performed on samples acquired via post 
mortem examination of animals suspected of being rabid and those that have been 
involved in potential human exposures (Nel & Markotter, 2007). In the latter case, it is 
imperative that a quick and reliable diagnosis be reached. This will ensure correct and 
timely administration of prophylactic measures to the exposed individual in order to 
prevent a fatal infection. Routine diagnostic tests are performed on brain tissue 
preparations of the medulla, cerebellum and hippocampus as the virus may not always 
disseminate efficiently to the other organs of the body (Nel & Markotter, 2007). 
Current diagnosis assays for lyssaviruses are discussed briefly in the subsequent 
sections.
2.1.1 Identification of Negri bodies
Historically, identification of discrete, intracytoplasmic, deeply eosinophilic 
inclusions called the Negri bodies in the brain specimen of the affected animal or 
human has been the method of choice for rabies diagnosis (Tierkel, 1973). However, 
such inclusion bodies were only detected in 50 % of samples obtained from the 
laboratory-infected cases (GDC, 2010) and hence the diagnosis based on these is often 
inefficient.
2.1.2 Fluorescent antibody test
With the advent of monoclonal antibodies, tests such as the direct fluorescent 
antibody test (dFAT) were introduced as the gold standard for detection of rabies
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virus. The test involves fluorescent microscopic detection of the fluorescein 
isothiocynate (FITC) - labelled antibody directed against the nucleoprotein of the virus 
capsid (Dean, 1996). Apart from brain preparations, samples obtained from the nuchal 
skin biopsies of the suspected rabies infected individuals could also be assessed 
through this test (WHO, 2008). Fresh, frozen or glycerolized specimens can be 
examined by dFAT. Formalin fixed samples cannot be used for the test as the formalin 
in the sample may mask the antibody-binding sites on the viral antigens (Whitfield et 
al., 2001). Different panels of monoclonal antibodies against different genotypes of 
lyssaviruses exist, however, dFAT is standardized to detect but not differentiate 
genotypes 1, 5 and 6 of lyssaviruses (Wiktor & Koprowski, 1980; Bourhy et a!., 1992; 
Markotter et a!., 2006a; Markotter et a!., 2006b). Resolution of genotypes has 
implications in devising appropriate control measures and epidemiological 
investigations.
2.1.3 Immunohistochemical test
An alternative antigen detection method which proved to be equally sensitive 
and specific to dFAT is the rapid immunohistochemical test [dRIT; (Niezgoda & 
Rupprecht, 2006)]. The dRIT uses the purified biotinylated monoclonal antibodies 
directed against the rabies virus nucleoprotein. Following a short incubation with 
streptavidin-peroxidase complex, the antibody-antigen binding complex is visualized 
by the addition of the substrate 3-amino-9-ethylcarbazole. The test can be performed 
in less than one hour, in contrast to dFTA, which usually requires 2 hours. Unlike dFAT, 
the dRIT can also be used on formalin-fixed test materials (Hamir et a!., 1995). The 
dRIT does not require any specialized equipment and therefore could be useful as a
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pen-side test in remote and under- equipped places. The only drawback to the method 
is that the test components have to be maintained at 4 °C prior to usage. 
Immunochromatographic techniques have also played a role in rabies virus antigen 
detection. Tests such as the rapid immunodiagnostic test (RIDT), which uses a lateral 
flow strip device coated with conjugated detector antibodies to trap specific viral 
antigen, have recently been developed (Kang etal., 2007). RIDT facilitates low-cost and 
rapid detection of rabies virus without the need for any specialized laboratory 
equipment. Preliminary assessment has indicated that the test could be used for rabies 
virus diagnosis, however, strenuous validations have to be performed on circulating 
variants of rabies virus. An enzyme-linked immunoassay tool, the rapid rabies enzyme 
immunodiagnosis (RREID), that is both cost effective and rapid has also developed 
(Perrin et al., 1986). This test can analyse salivary gland specimens but not brain 
samples.
2.1.4 Virus neutralisation test
Virus neutralisation tests such as the fluorescent antibody virus neutralisation 
test [FAVN; (Cliquet et al., 1998)] and the rapid fluorescent focus inhibition test [RFFIT; 
(Smith et al., 1973)] also play a role in rabies virus diagnosis. These tests measure the 
level of rabies virus neutralising antibody in the vaccinated individuals and could also 
be used as an indirect assay to detect the presence of virus in non-immunized 
individuals. However, as the host response to infection varies substantially between 
individuals these tests may lack the desired sensitivity and specificity and thus are 
unsuitable as routine detection tools for lyssaviruses.
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2.1.5 Virus isolation
Virus isolation and propagation is facilitated by methods such as the rabies 
tissue culture infection test [RTCIT; (Sureau, 1986)] and mouse inoculation test [MIT; 
(Webster & Dawson, 1935)]. These tests are usually confirmatory to the preliminary 
diagnosis and also enable further characterisation of any virus sequence and 
phylogenetic evaluations. Samples such as brain suspension, saliva and other biological 
fluids such as tears or cerebrospinal fluid can be used for virus isolation. However, the 
RTCIT and MIT are disadvantaged by their lengthy turnaround time, 4 and 28 days, 
respectively. MIT is usually carried out if the required cell line for a particular lyssavirus 
is unavailable.
2.1.6 Molecular techniques
Molecular detection techniques such as PCR have gained remarkable value in 
the detection and diagnosis of lyssaviruses. PCR is an invaluable tool for detecting 
lyssaviruses from decomposed specimens, archival tissues and from samples with low 
viral load such as saliva and cerebrospinal fluid. A heminested PCR was initially 
developed that involves an RT step prior to  primary and heminested amplification 
steps (Heaton et al., 1997). Instead of performing the laborious process of brain 
dissection, the PCR could be performed on a core brain sample extracted via the retro- 
orbital or occipital foramen route using a disposable pipette (Barrat & Hallek, 1986; 
Hirose et al., 1991). However, the heminested PCR suffers drawbacks such as lengthy 
turnaround time and cross contamination as the process involves multiple transfers of 
targets for successive reactions. Even though PCR amplifies representatives of all seven
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lyssavirus genotypes, DNA sequencing also has to be performed to define the 
lyssavirus genotype. To address the limitations involved in PCR, a real time TaqMan 
PCR is the latest to be developed for lyssavirus detection (Wakeley et al., 2005). This 
TaqMan PCR is a rapid detection assay and allows quantification of sequence specific 
template in real time. The target specificity in TaqMan PCR is ensured by the internal 
probe and the inherent single tube test minimises cross contamination (Gibson et al., 
1996; Heid et al., 1996b). This TaqMan PCR utilizes a pan-lyssavirus primer set that 
amplifies a large panel of lyssaviruses, with probes specifically designed to discriminate 
between RABV, EBLV-1 and 2 (Wakeley et al., 2005). However, the lack of availability of 
primers and probes for the remaining genotypes (2, 3, 4 and 7) and their circulating 
variants are limiting factors for the assay (Fooks et al., 2009).
Other molecular techniques such as nucleic acid sequence-based amplification 
[NASBA; (Wacharapluesadee & Hemachudha, 2001)] and loop mediated isothermal 
amplification [LAMP; (Wakeley, 2009)] have also been successfully shown to have 
comparable sensitivity and specificity to that o f the TaqMan PCR. The assays were both 
tested with ante mortem samples, saliva and cerebrospinal fluid. The NASBA technique 
utilizes three enzymes (RT, RNase H and T7 RNA polymerase) for synthesis of multiple 
copies of target RNA under isothermal conditions. The amplified RNA is detected and 
quantified using an automated reader. The assay can detect rabies virus as early as two 
days after the onset of symptoms (Fooks et al., 2009). In contrast to NASBA, LAMP 
utilises two primer sets (inner and outer) for generation of large quantities of 
template. The process can be monitored by incorporating a double stranded DNA 
binding fluorophore such as picogreen or by gel electrophoresis analysis.
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The aim of this study was to design a mini DNA microarray chip so that 
simultaneous detection and typing of the seven genotypes of lyssaviruses could be 
achieved. This was in addition to detection of four unclassified strains.
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2.2 Materials and methods
2.2.1 Virus strains and RNA extraction
The details of each lyssavirus isolates used in the study were provided by Dr. 
Nick Johnson, rabies and Wildlife Zoonoses group, AHVLA, Weybridge, and are listed in 
the Table 2.1. Each virus homogenate from suspected and quarantine cases in the UK, 
was inoculated intracranially into 3-week-old mice (Swiss OFl or GDI). Upon 
development of disease, mice were euthanised and RNA was extracted from the brain 
using TRIzol (Invitrogen) as per the manufacturer's instructions. RNA extracted from an 
uninfected mouse brain was used as control for microarray normalisation. The RNA 
was resuspended in water, quantified using a Nanodrop (Thermo Scientific) and 
diluted to  0.5-1 pg/pl. Vesicular stomatitis virus (VSV) RNA was kindly provided by Dr. 
Falko Steinbach, AHVLA. The virus, a non-lyssavirus member of the family 
Rhabdoviridae, was used as a specificity control for lyssavirus probes.
Genotype Virus Isolate Host Country of origin
1 Rabies virus RV64 Raccoon-dog Poland
2 Lagos bat virus RVl Bat Nigeria
3 Mokola virus RV39 Shrew Cameroon
4 Duvenhage virus RV175 Feline Zimbabwe
5 European bat lyssavirus RV19 Bat Denmark
6 European bat lyssavirus RV628 Bat United Kingdom
7 Australian bat lyssavirus RV634 Bat Australia
Table 2.1: List of all the lyssavirus genotypes used in the study. Each virus is detailed 
by isolate name, host, and the country of origin.
66
2.2.2 DNase digestion
RNA samples (up to a concentration of Ipg) were digested with amplification 
grade DNase I (Invitrogen) following the manufacturer's protocol to remove DNA 
contaminants. In brief, 1-2 pi o f DNase I (1 u/pl) and 1 pi of lOx DNase buffer were 
added to 7 pi of RNA (about 3.5 pg) and the final volume was adjusted to 10 pi. The 
mix was incubated for 15 minutes at RT. DNase I was then inactivated by the addition 
of 1 pi of 25 mM EDTA solution and heating for 10 minutes at 65 °C.
2.2.3 cDNA synthesis
DNase I digested RNA was added to 1 pi of 25 mM dNTP (Promega) and 1 pi of 
40 pM random primer A, 5' GTT TCC CAG TCA CGA TAN NNN NNN NN 3' (Joseph 
DeRisi, personal communication). The mixture was heated at 65 °C for 5 minutes and 
chilled on ice immediately. Four pi 5 x RT buffer (Invitrogen), 1 pi 0.1 M DTT, 1 pi 
RNasin ribonuclease inhibitor (20-40 u/pl, Promega) and 1 pi Superscript III (200 u/pl, 
Invitrogen) were added to the mix, incubated at 42-50 °C for 60 minutes and then 
heated to 70 °C for 15 minutes.
2.2.4 Sequence-independent amplification method
The sequence-independent nucleic acid amplification, also called random 
amplification, used in the study was based on the method previously described by 
Wang et al., (2002). Briefly, cDNA was denatured at 94 °C for 2 minutes and rapidly 
cooled to 10 °C for 5 minutes. Two pi 5x Sequenase buffer (USB, Ohio) and 0.3 pi
67
Sequenase DNA polymerase were added to the mix and the total volume was adjusted 
to 30 pi. The mixture was heated slowly from 10 °C to 37 °C over an 8 minute period 
and held at 37 °C for another 8 minutes. The cycle was repeated with 0.3 pi of fresh 
Sequenase and terminated by heating the reaction at 94 °C for 8 minutes.
Double stranded DNA template (5 pi) was amplified in a PCR composed of 5 pi of lOX 
KlenTaq PCR buffer (Sigma), 0.5 pi of 25 mM dNTP mix, 1 pi of primer B, 5' GTT TCC 
CAG TCA CGA TA 3' (Joseph DeRisi, personal communication), 1 pi KlenTaq* LA DNA 
polymerase (5 units/pl) and the final volume was adjusted to 50 pi with water. The 
PCR mix was heated to 94 °C for 4 minutes and 68 °C for 5 minutes before being 
subjected to 35 cycles of 94 °C for 30 seconds, 50 °C for 1 minute and 68 °C for 1 
minute, followed by a final extension of 2 minutes at 68 °C and then held at 10 °C.
2.2.5 Quantitative PCR (qPCR)
A real time qPCR (Wakeley et al., 2005) which amplifies a 110 bp nucleotide 
region of the N gene, were employed to estimate template copy number before and 
after random amplification. The forward, JW12 5'- ATG TA A CAC CYC TAC AAT G- 3', 
and reverse, N165-146 5'- GCA GGG TAY TTR TAC TCA TA -  3', primers were 
corresponding to the nucleotides 55-73 and 165-146 on the rabies virus genome 
(Pasteur strain, accession number NC_001542) respectively. The qPCR was carried out 
at 94 °C for 2 minutes followed by 45 cycles of 95 °C for 1 minute, 55 °C for 30 seconds 
and 72 °C for 20 seconds using Brilliant* II SYBR* Green QPCR master mix (Stratagene) 
as per the manufacturer's instructions. Product from sequence-independent 
amplification was diluted 1:10 with deionised water before being quantified by qPCR.
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2.2.6 Labelling of target DNA
Indirect labelling of amplified products was achieved in a second round of PCR 
and subsequent coupling of dye to the target. The PCR consisted of 5 pi of lOX KlenTaq 
PCR buffer, 1 pi of KlenTaq* LA DNA polymerase (5 units/pl), 1 pi of amino allyl dNTP 
mix [10 mM amino allyl dUTP (Ambion), 2.5 mM dTTP, and 12.5 mM of each dGTP, 
dCTP and dATP], 1 pi of 100 mM amino-primer B, amino-C6 5' GTT TCC CAG TCA CGA 
TA 3' (Joseph DeRisi, personal communication) and 5 pi of first round PCR product in a 
total volume of 50 pi. The PCR conditions were the same as before but were run for 15 
cycles. The PCR product was purified with the MinElute PCR purification kit (Qiagen) 
and DNA was eluted in 10 pi of water. The eluted DNA was coupled to AlexaFluor 555 
reactive dye (Invitrogen) dissolved in 4 pi of DMSO (SIGMA-Aldrich, USA) in the 
presence of 6 pi sodium bicarbonate (25 mM) (SIGMA-Aldrich, USA) for 1 hour at RT in 
the dark. After the incubation, the coupling reaction volume was adjusted to 50 pi 
with water and unincorporated dye was removed using illustra AutoSeq™ G-50 
columns (GE Healthcare) according to the manufacturer's instructions. The 
concentration of the labelled DNA was calculated with Nanodrop (Thermo Scientific). 
The frequency of dye incorporated (FOI) was calculated using the formula: 324.5 x 
picomoles of dye incorporated/ concentration of the sample (ng/pl).
2.2.7 Hybridisation
Microarray glass slides were immersed in prewarmed (50 °C) pre-hybridisation 
solution [5x SSC (Sigma), 0.1 % SDS (Fluka), 4x Denhardt's solution (Invitrogen) in
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deionised H2O] for 30 minutes, washed briefly for 1 minute with deionised water and 
Isopropanol (RathBurn chemicals) and dried by low speed centrifugation (1000 rpm in 
Centaur 1 MSE centrifuge) for 5 minutes.
Labelled target DNA (30 pi) was denatured at 95 °C for 3 minutes and chilled on 
ice. An equal volume of 2x hybridisation buffer (5x SSC, 1 % SDS, 4x Denhardt's 
solution) was added to the denatured target and loaded onto the glass array. Briefly, 
the glass array was inserted into the assembly Jig (BioMicro Systems, USA) with the 
oligo side upwards. The adhesive backing was removed from the MAUI mixer AO and 
the mixer was fixed onto the slide surface. The mixer and the glass slide were then 
removed from the assembly jig and attachment of the MAUI mixer was further 
enforced by pressing with the MAUI brayer. The labelled target was then applied to 
the glass slide through openings in the MAUI mixer and hybridisation was performed 
on a MAUI Hybridisation station (BioMicro Systems) on mix mode D at 50 °C overnight.
2.2.8 Washing, scanning and data anaiysis
The microarray slide with hybridized labelled target DNA was washed manually 
with gentle inversions for 2 minutes in buffer A (Ix  SSC, 0.2 % SDS in deionised H2O) at 
50 °C, 2 minutes in buffer B1 (O.lx SSC, 0.2 % SDS in deionised H2O) at 55 °C, 2 minutes 
in buffer B2, O.lx SSC at room temperature and dried by low speed centrifugation. The 
microarray image was captured with a GenePix 4000B scanner (Molecular Devices) and 
analysed with GenePix Pro 6.1 software. Statistical analysis of the data was performed 
with DetectiV software (Watson et al., 2007). DetectiV is implemented as a package for 
R, a powerful and open access statistical programming package (http://www.R- 
project.org). The 'median' and 'array' methods of normalisation were used in the
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statistical analysis of the results. The median method calculates the global median 
value for each array. It should be noted that this method assumes that most probes 
will not hybridize to anything. The global median value for each array is then used as a 
divisor for each probe on their respective arrays.
. The 'array' method utilizes an entire control array, e.g. RNA from a known uninfected 
animal, as the negative control and all probe values are divided by their respective 
values from the control array performed on a separate slide. In both methods, non­
hybridised probes should be normally distributed and have a mean of zero. The probes 
are then split into groups and a t-test is performed for each one to test differences of 
the observations from zero. The median value for each set of probes and their ratio to 
the global median or control array is calculated, log to the base 2 (log2) is taken and 
the outputs are sorted by p value and presented.
2.2.9 Lyssavirus genotyping probe design
A 405 base pair nucleotide sequence of the N gene (Figure 1.16), corresponding 
to nucleotide 71 to 470 of the Pasteur strain of RABV (accession number NC_001542), 
was used to design genotyping microarray probes for lyssaviruses. The DNA sequences 
of the N gene for virus species in each genotype were aligned using MegAlign software 
(LaserGene Version 7.0) and their consensus nucleotide sequence was extracted. The 
consensus was then used as a template to design genotypic probes. The probes were 
70mer oligonucleotides that overlap by approximately 45 bases. The SeqMan software 
(LaserGene version 7.0) was applied to compare the nucleotide sequences of each 
probe to that of the probes designed to other genotypes. Probes with similarity of 
more than 90 % in nucleotide were removed to avoid cross hybridisation.
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The probe representation of lyssaviruses were 25 probes for genotype 1, 14 
probes for genotype 2,15 probes for genotype 3,14 probes for genotype 4,17 probes 
for genotype 5, 15 probes for genotype 6 and 20 probes for genotype 7. There were 
also 14 probes for each of the unassigned lyssaviruses; Aravan, Khujand, Irkut and 
West Caucasian bat viruses. All the probes were printed in duplicate on each slide.
2.2.10 DNA chips and printing process
The LP chip and BioChip version 3.1 were used for the microarray studies in this 
chapter. The LP chip consisted of 624 probes; 134 for lyssaviruses and 490 for 
pestiviruses, GEO accession number GPL8066. The BioChip version 3.1 (GEO accession 
number GPL5725) contained 2884 probes spanning across 35 virus families.
The 60-mer oligonucleotides were synthesised commercially (Eurofins MWG Operon) 
on a scale of 50 nmoles and resuspended in 15 pi of water. The oligonucleotides were 
then mixed with equal volume of spotting buffer (25 % DMSO, 1.5 x SSC and 10% SDS) 
before being spotted on the Epoxy-coated glass slides (Schott Nexterion). Printing was 
done in house using Bio Robotics Migrogrid II robot (Digilab Inc.) and previously 
published protocol (Burton et al., 2005). The Cy3 landing light (Sigma) was used at a 
concentration of 5 pM in spotting buffer to mark corners of each subarray for GAL file 
alignment and feature extraction.
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2.3 Results
2.3.1 Amplification efficiency of random ampiification
A qPCR which amplifies a 100 nucleotide segment of the N gene coding region 
of the rabies virus RNA (accession number NC_001542) was performed to assess 
amplification efficiency of sequence-independent PCR. The qPCR was carried out on 
the double stranded DNA (dsDNA) generated from lyssavirus RNA and on the 
corresponding randomly amplified PCR products. A minimum of 1000-fold increase in 
the initial templates was observed following 35 cycles of amplification (Table 2.2). The 
highest increase in DNA copy number in random amplification was 10  ^fold.
Genotype Virus Isolate Host
Country of 
origin
Initial dsDNA 
copy ho.^
Copy no. before 
labelling®
1 Rabies virus RV64
Raccoon-
dog
Poland 1.379e+05 2.441e+10
2 Lagos bat virus RVl Bat Nigeria ND" ND
Mokola virus RV39 Shrew Cameroon 1.174e+03 1.696e+06
Duvenhage
virus
RV175 Feline Zimbabwe 8.686e+01 1.379e+07
5
European bat 
lyssavirus
RV19 Bat Denmark 1.058e+04 8.302e+09
6
European bat 
lyssavirus
RV628 Bat
United
Kingdom
5.845e+03 5.529e+09
'
Australian bat 
lyssavirus
RV634 Bat Australia 3.528e+01 2.351e+07
Template copy number was measured by real time qPCR on double-stranded DNA (dsDNA) produced from viral 
RNA by reverse transcriptase and Sequenase enzymes.
Final viral cDNA copy number was measured by real time qPCR on the randomly amplified PCR products.
NO, not done.
Table 2.2: Information on the 7 lyssavirus isolates used in the study aiong with the real time 
qPCR vaiues to depict amplification efficiency of random PCR. The qPCR was carried out on 
the dsDNA (generated from viral RNA) and on corresponding randomly amplified PCR 
products. The increase in dsDNA templates ranged from 10^  (genotype 3) to 10® (genotypes 4, 
6 and 7) fold in random PCR following 35 cycles of amplification.
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2.3.2 Microarray genotyping of iyssaviruses
The nucleic acids from 7 different lyssavirus isolates, each representing one of
the 7 genotypes, were tested on the lyssavirus/pestivirus (LP) microarray. The chip 
correctly identified and distinguished the 7 lyssavirus genotypes (Table 2.3) using both 
'median' and 'array' methods of normalisation. For each genotype, the largest mean 
normalized logz ratio combined with the smallest and/or statistically significant p value 
(p < 0.01) was applied to identify the sample. There were several orders of magnitude 
between the p values for the top hit and that for the other genotypes. Figure 2.1 
illustrates a representative bar plot (2.1A) and tabulated top virus hits (2.1B) for the 
lyssavirus genotype 4 (Duvenhage virus) RNA on the LP chip. The mean normalized log: 
ratios are sorted on decreasing magnitude and the 4 top virus hits are shown. 
Lyssavirus genotype 4 is correctly identified by the chip having the biggest mean 
normalized log2 ratio and p < 0.01.
To verify the results produced on the LP chip, the rabies virus (genotype 1) was 
also tested on the more comprehensive BioChip version 3.1 (Figure 2.2). Rabies virus is 
the only lyssavirus on the array and represented with only 5 probes. Rabies virus came 
as the top hit with a mean log2 ratio of 10.8 and p value of 4.94e-06. Even though 
probes for the avian encephalomyelitis-like Virus, Ljungan virus and swine vesicular 
disease virus produced significant p values (p < 0.05), their mean values were 
significantly lower (by 8 log2) than that o f rabies.
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Viruses detected by 
microarray
No. of 
probes
t value p value Mean logz
Lyssavirus genotype 4 28 9.70 1.37e-10 3.20
CSFV 32 3.80 0.0003 0.90
BDV strain X818 2 2 3.90 0.0004 0.80
BVD strain 11205/98 1 0 4.60 0.0006 0.50
Figure 2.1: A; Bar plot generated from a lyssavirus genotype 4 (Duvenhage virus) RNA 
from mouse brain tested on the LP chip. Each probe is indicated by a single bar. The Y 
axis shows the raw fluorescence intensity. The probes for the lyssavirus genotype 4 
show the highest fluorescence intensity. Landing lights were used to locate the 
position of each subarray on the chip to facilitate alignment of GenePix Array List (GAL) 
file for feature extraction. B; Analysis of mean fluorescence value for virus probes by 
DetectiV software using median normalisation. Lvalue represents the result of the T- 
test. The normalised mean logi ratios for the probes were sorted on their decreasing 
magnitude and the four top hits are shown. The top hit, lyssavirus genotype 4 (G4) is 
clearly distinct in having the largest mean normalised logz ratio and the smallest p 
value.
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A;
>I  I
B;
Viruses detected by microarray No. of 
probes
t value p value Mean Icg2
Rabies virus 1 0 8.80 4.9e-06 10.80
Swine vesicular disease virus 5 1.60 0.09 3.20
Avian Encephalomyelitis-like Virus (L2Z) 9 1.90 0.05 2.52
Ljungan virus 1 0 1.70 0.06 2.50
Figure 2.2: A; Bar plot generated from a BioChip version 3.1 microarray which was 
analysed by DetectiV and array method of normalisation. The sample was rabies virus 
(lyssavirus genotype 1) RNA from mouse brain, which was amplified randomly by PCR. 
Each probe is indicated by a single bar. The Y axis shows the raw fluorescence 
intensity. B; Analysis of mean fluorescence value for virus probes by DetectiV 
software using median normalisation. The four top hits are listed in the decreasing 
order of mean value. The top hit, rabies virus, is clearly distinct in having the largest 
mean normalised logz ratio and a significant small p value.
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VSV, a rhabdovirus in the Vesiculovirus genus of the family Rhabdoviridae, was 
tested on BioChip version 3.1 chip to further examine the specificity of the lyssavirus 
genotype 1 probes. On the chip, DetectiV has provided a clear distinction in both mean 
log2 ratio (6.9) and the p value (1.2e-05) compared to the other successive hits (Perch 
rhabdovirus, avian sarcoma virus and Japanese encephalitis virus). VSV is identified as 
the top hit using median normalisation (Table 2.4). VSV did not show any significant 
similarity (p > 0.05) to the lyssavirus genotype 1 on the array, as expected.
Viruses detected by microarray No. of 
probes
t value p value Mean
log2
Vesicular stomatitis virus 1 2 6.90 1.2e-05 4.30
Perch rhabdovirus 6 2.60 0 . 0 2 2 1.80
Avian sarcoma virus 5 2.90 0 . 0 2 0 1.30
Japanese encephalitis virus 5 2.80 0 . 0 2 1 1 .1 0
Table 2.4: A table to  depict the top virus hits sorted on decreasing magnitude of their 
mean logz ratios when a VSV sample was tested on the BioChip version 3.1. The
experiment was to show the specificity of lyssavirus genotype 1  probes by testing a 
non lyssavirus member of Rhabdoviridae. The VSV probes topped the table with a 
significant p value and the largest mean normalized log] ratio. None of the lyssavirus 
genotype 1 probes show significant homology to the VSV RNA.
2.3.3 Microarray on coded samples
To further test the ability of the LP chip to identify lyssaviruses at the genotype 
level, we performed microarray detection on a panel of 5 coded samples and analysed 
the outputs by 'median' and 'array' methods of normalisation (Table 2.5). The nucleic 
acid extracted from the brain of the uninfected mice was used as the control for 'array' 
method. The array method of normalisation accurately identified all the coded virus
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samples at the genotype level. However, the median method failed to identify 
lyssavirus in one of the coded samples, RV (USA) isolate,as the top hit on either mean 
or p values. The array normalisation is therefore, proved to have a higher degree of 
accuracy in identifying lyssaviruses.
Coded Isolates
Top hit 
[mean log2 and p values]
samples Median normalisation Array normalisation
A RV105 (Morocco) Lyssavirus Gl^ [2.8 (1.2e-15)j Lyssavirus G l, [10.5 (8.2e-23)j
B RV (USA) n d '’ Lyssavirus G l, [8.1 (9.7e-20)j
C Water ND ND
D RV266 (France) Lyssavirus G5, [2.7 (1.8e-15)j Lyssavirus G5, [11.6 (2.7e-16)]
E RVl 143 (Turkey) Lyssavirus G l, [1.0 (2.1e-10)] Lyssavirus G l, [5.5 (4.0e-10)j
F RV425 (South Africa) Lyssavirus G l, [2.9 (3.2e-17)j Lyssavirus G l, [10.6 (4.3e-23)]
; Lyssavirus genotypes 
No lyssavirus was detected as top hit based on mean or p values.
Table 2.5: Detection of lyssaviruses in coded samples by LP chip. Five coded lyssavirus 
samples were tested on the LP chip to evaluate the two normalisation methods by the 
DetectiV software. The table shows the comparison of normalized mean log: ratios and 
p values in median and array normalisations for top hits of each coded sample.
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2.4 Discussion
Rabies remains an important public health problem, principally within 
developing countries, with the disease killing an estimated 2 0 , 0 0 0  people annually in 
India alone (Sudarshan et al., 2007). Occasional cases also occur in the developed 
world through exposure of travellers to rabies endemic areas (Johnson et a!., 2005) or 
through encounters with infected bats (Messenger et a!., 2003). A compounding issue 
in the devising of detection assays for lyssaviruses is the presence of multiple lyssavirus 
genotypes in many areas of the world, most of which are known to cause disease in 
humans (Fooks et a!., 2003; Paweska et a!., 2006). Rapid in vivo diagnosis o f the 
disease in humans is also problematic due to the low levels of virus present in 
accessible samples such as saliva and CSF. The aim of this study was to evaluate the 
potential of DNA microarrays as a multiplex diagnostic tool for lyssaviruses. Here we 
demonstrate that a tailored microarray (LP chip) offers the ability to detect and 
distinguish the seven recognised members of the lyssavirus genus using an array 
containing 272 unique 70mer probes. This approach may, in principle, be used to 
diagnose rabies in humans and animals.
The N gene was selected as the target for the microarray assay as the degree of 
conservation among the seven lyssavirus genotypes was considered low enough to 
generate species-specific probes. The N gene has been extensively used to detect and 
classify lyssavirus isolates into their respective genotypes (Kissi et ai., 1995; Bourhy et 
al., 1999). Furthermore, there is a significant amount of sequence data available for 
the N gene worldwide, thereby facilitating probe design.
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The oligonucleotide probes used in the experiments were overlapping 70mers 
allowing a higher degree of tolerance for a target to hybridize to a non-matching but 
related sequence. 60mer probes can tolerate mismatches of 5 nucleotides and 
therefore allow hybridisation from divergent isolates (Palacios et al., 2007). 
Furthermore, the concentration of formamide and temperature are two key elements 
in the stringency in which hybridisation occurs. Therefore, a sodium dodecyl sulphate- 
based hybridisation buffer, without formamide, was selected to allow for 
hybridisation of targets with several mismatches in case of divergent isolates. The 
hybridisation was also performed at a lower temperature of 50 °C to allow binding of 
imperfect matches. The Tm of probes was ranged from 70 °C to 80 °C.
The microarray results on the seven genotypes of lyssaviruses were 
encouraging since all genotypes were correctly identified. Fiowever, there are 
challenges that need to be fixed before such a microarray assay can achieve diagnostic 
standards. The most challenging problem is the sensitivity of the arrays for detection 
of viruses in clinical samples considering the random amplification of target materials. 
A general approach to improve the detection sensitivity of microarray may be the 
removal of non-viral DNA and RNA. We DNase-treated lyssavirus RNA to deplete host 
DNA prior to random amplification. Nuclease treatment is used under certain 
circumstances on clinical samples prior to RNA or DNA isolation to reduce non-viral 
DNA under the assumption that viral nucleic acids are protected from DNase 
degradation by the viral capsid and envelope (Allander et a!., 2001; Clem, 2007). 
Alternatively, removing large ribosomal RNA from viral RNA samples by capture 
methods, besides DNase treatment, could further improve the sensitivity of randomly
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primed amplification. At present the sensitivity of the microarrays is an issue to be 
improved. However, the technology offers the ability to screen clinical samples for a 
large number of pathogens simultaneously and consequently provide an add-on value 
to frontline routine laboratory tests. Microarray screening can be done either at intra 
vitom or post mortem diagnosis as appropriate.
Microarray printing of reproducible quality requires certain quality standards to 
be applied in order to achieve consistent print quality among and between batches. 
Such a degree of robustness and reproducibility is unlikely to be achieved by in-house 
contact printing methods. This, however, can be ratified by use of platforms such as 
Agilent inkjet printing platform (Agilent technologies). Also, all tests dealing with 
notifiable diseases such as rabies should aim to achieve accreditation to ISO 17025 or 
comparable standards, thus requiring extensive validation with a range of clinical 
samples to demonstrate specificity, sensitivity and robustness. This, however, was not 
aimed for in this proof of concept study.
Microarray images were analysed by DetectiV software using both median and 
array methods of normalisation. The array normalisation proved to have a higher 
degree of accuracy in identifying lyssaviruses and this study suggests that this method 
of normalisation is acceptable for microarray data for detection within clinical samples.
In conclusion, I have described here the use of a DNA microarray-based assay 
to simultaneously detect and discriminate lyssaviruses at the genotype level in 
biological samples. This may form the basis for a diagnostic BioChip.
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Chapter 3:
Development of a genotyping microarray for classical
swine fever virus
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3.1 Introduction
Diagnosis of CSFV infections are routinely carried out on clinical signs, gross 
pathological observations at post mortem, serology and detection of virus antigen and 
nucleic acid. Current methods are briefly described below.
3.1.1 Diagnosis of CSFV infection in pigs based on ciinicai signs
Diagnosis of CSF in pigs based on clinical signs is primarily reliant on the 
severity of infection. Several factors such as the virulence of CSFV, the age of the pigs 
and other host factors can contribute to the clinical course of the disease (Mittelholzer 
et al., 2000; Niesmann et al., 2003). Younger animals are usually severely affected and 
display the classical haemorrhagic form of the disease (Depner et al., 1997; Kaden et 
al., 2004). The infection in older breeding pigs is often mild or even subclinical. There 
are no pathognomonic signs associated with the disease and other invading viral 
pathogens often exacerbate the disease symptoms. Clinical signs of CSF infection also 
tend to overlap with those of other viral infections such as African swine fever, porcine 
dermatitis and nephropathy syndrome (PDNS) as well as bacterial septicaemias and 
other haemolytic diseases of newly born piglets (Moennig, 1992). In spite of the 
unspecific clinical signs in CSFV infections, experienced veterinarians can still diagnose 
the disease on clinical signs. Most of the 270 outbreaks that occurred in Germany 
between 1990-1998 were diagnosed on clinical manifestations of the disease 
(Fritzemeier et al., 1997). However, there is often a long critical phase from CSFV 
infection to detection of the outbreak. In densely populated pig herds such delay can
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lead to devastating CSF epidemics and huge economic loss (Engel et al., 2005a). 
Therefore a rapid diagnosis is extremely important.
3.1.2 Diagnosis of CSFV infection in pigs based on pathology
Pneumonia, pleuritis, chronic bronchitis and gastric ulceration, pulmonary 
oedema, conjunctivitis, splenomegaly and renal, urinary bladder and lymph nodes 
haemorrhages are commonly seen in post mortem inspection of CSF infected pigs. 
Many of the pathological observations e.g. pneumonia and pleuritis, are not specific to 
CSF infection (Elbers et al., 2003) but the occurrence of such lesions in CSF cases is 
substantially higher. In the 1997 outbreak of CSF in Netherlands, the disease was first 
identified by routine post mortem examination of infected pigs (Smit et al., 1999; 
Elbers et al., 2003).
3.1.3 Seroiogical detection of CSFV infection in pigs
Serological assays are often employed for routine CSFV diagnosis and for 
screening pigs for previous CSFV exposures. The most commonly used assays to detect 
antibody to CSFV are the VNT and ELISA (Greiser-Wilke et al., 2007). The VNT is 
considered as the gold standard but suffers from drawbacks such as being laborious, 
time consuming and reliant on replication of the virus in cell culture (OIE, 2008a). The 
VNT test is also unsuitable for large scale screening of serum samples as it cannot be 
automated.
CSFV antibody ELISAs are aimed to detect antibodies to the E2 glycoprotein 
(Niesmann et al., 2003) and E protein (Moormann et al., 2000). The assay is
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designed as blocking (Wensvoort etal., 1988) and indirect (Moser et o/., 1996) formats. 
Unlike VNT, ELISA can be easily automated for mass screening of samples within a 
short period of time but is prone to cross reactivity with antibodies to other
pestiviruses (Niesmann, 2001; Loeffen et al., 2005). Antibodies to CSFV appear 2-3
\
weeks after infection, which renders serology unsuitable as a tool for early diagnosis of 
CSF infection. Serological assays also cannot differentiate between vaccine and field 
strains. However, despite the limitations, serological tests are still extremely useful for 
diagnosis and monitoring of CSFV infections worldwide.
3.1.4 Detection of CSFV antigen and nucieic acid
Detection of CSFV antigen can be performed directly on clinical specimens or 
indirectly on the virus grown in cell culture. Immunofluorescence (IFT) and IPX tests 
have been used to directly detect CSFV in tissues from infected pigs (OIE, 2008a). The 
assay processing time is short and therefore it can be applied as the frontline tool for 
laboratory investigation of suspected outbreaks. During the Netherlands epizootics in 
1997-1998, 82 % of the 426 outbreaks were diagnosed by direct I FT on the cryostat 
sections of tonsils (Smit et a!., 2000). In experimentally infected pigs, IPX could detect 
CSFV in tonsils from 2-15 days post infection. However, the tests suffer such drawbacks 
as nonspecific staining of non-viral components and requirement for skilled personnel.
CSFV antigen detection can be achieved by virus isolation in cell lines such as 
porcine kidney cells, PK15 and SK6  (Grummer et a!., 2006). The virus however, does 
not produce CPE and assays such as direct/indirect I FT are required to confirm virus 
replication. The test, although time consuming, is very reliable and considered as the
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gold standard for detection of CSFV in any outbreak (OIE, 2008a). The viral stock 
produced in cell culture could also be used for further genotyping analysis.
PCR is a sensitive and reliable method for detection of CSFV, especially in 
samples where a low load of CSFV is expected e.g. early stages of the infection. Several 
PCR protocols for CSFV detection are in routine use. The PCRs target the E2 
glycoprotein sequence (Katz etal., 1993), the NS5b non-structural protein region (Arce 
et al., 1998) or the 5'UTR region (Aguero et al., 2004) of the genome. The PCR 
targeting the E2 region is a nested PCR with primary and secondary amplicons of size 
308 and 172 bp, respectively. Two other CSFV-specific PCR protocols have been 
developed to detect new virus isolates. The PCRs amplify a 521 bp fragment covering 
partly the 5'UTR and the N sequence (Greiser-Wilke et al., 1998) and a 671 bp 
segment of the E2 region (Paton et al., 2000). Real time PCRs have provided a 
distinctive advantage over conventional PCR in CSFV diagnosis. The real time PCR is 
more sensitive, requires a shorter run time and is less prone to contamination. A 
published real time PCR for CSFV detection targets a fragment of the 5' NTR (Floffmann 
et al., 2005). Several other real time PCRs for CSFV detection have been developed by 
commercial companies such as Laboratory Service International (France) and 
ADIAGENE (France) which target the 5' UTR of the virus genome (Potier et al., 2006). 
However, sequencing is required to confirm PCR results and resolve the causative 
genotype for epidemiological studies. Therefore the aim of this study is to  design a 
mini DNA microarray chip so that simultaneous detection and genotyping of the 
known 10 sub-genotypes of CSFV can be achieved.
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3.2 Materials and methods
3.2.1 Viruses and RNA extraction
3.2.1.1 CSFV sub-genotypes
CSFV strains representing 9 sub-genotypes were kindly provided by Dr. Flelen 
Crooke, Mammalian Virology, AFIVLA, Weybridge (Table 3.1). The viruses were 
cultured in porcine kidney (PK-15) cells as described previously (Drew, 2008). Other 
pestiviruses used in the microarray analysis, bovine viral diarrhoea virus (BVDV) 
Oregon C24V (McGoldrick et al., 1999) and border disease virus S137/4 (McGoldrick et 
al., 1999) were kindly provided by Jill Sharp, Mammalian Virology, AFIVLA, Weybridge. 
The viruses were grown in foetal bovine testes cells in Eagle's minimum essential 
medium (EMEM) (Invitrogen) and 10 % foetal calf serum (FCS). The culture 
supernatant on days 4 or 5 post infection was harvested and used for RNA extraction. 
The sub-genotype 3.2 was not available for this study, therefore, a 190 bp synthetic 
DNA corresponding to the E2 region of the Korean isolate 96 (Hanover database 
cataloguing number 96939) (Greiser-Wilke et al., 2000)] was used as the target in the 
genotyping experiments.
3.2.1.2 Experimentally CSFV infected pig tissues
Experimentally CSFV infected pig tissues were kindly provided by Dr. Helen 
Everett. The tissues were from 10 week old piglets that had been intranasally infected 
with CSFV UK 2000 and CBR 93 strains with an infectious dose of lO^TCIDso (Everett et 
al., 2009). Upon development of infection, the animals were euthanised and 
retropharyngeal lymph node (UK 2000) and tonsil (CBR93) were removed. The tissues
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were homogenized in an OMNI TH homogenizer (Omni International, USA) in the 
presence of hypotonic buffer comprised of 10 mM KH2PO4 and clarified by low speed 
centrifugation at 3000 rpm for 5 minutes in a Hettich Mikro 200R centrifuge. CSFV RNA 
was extracted using the QIAmp Viral RNA mini kit (Qiagen).
3.2.1.3 Non pestivirus controls
The RNA from tick-borne encephalitis virus (TBEVj and West Nile virus (WNV), 
two non pestiviruses in the family Flaviviridae, were kindly provided by Dr. Nick 
Johnson, Rabies and Wildlife Zoonoses, AFIVLA, Weybridge. The RNA was extracted 
from brains of infected mice using TRIzol (Invitrogen) as per manufacturers' 
instructions.
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Sub-genotype Virus/Hannover database cataloguing number^ Country/Isolation
year
1 .1 Alfort 187^(reference strain) /CSF0902 France /1968
1 .2 Malaysia 67^ /  NA^ Malaysia /1967
1.3 Malaysian 85^ /  VRI2658 Malaysia /1985
2 .1 UK2000/CSF0708 U K /2000
2 .2 SS339-96/CSF0152 Austria /1996
2.3 Rostock/CSF0084® Germany / 1992
3.1 Congenital Tremor /  CSF0410 U K /1964
3.2 NA* NA*
3.3 CBR93VXXX0008 Tha iland/1993
3.4 Kanagawa /  CSF0309 Japan /1974
2000. Fritzemeier eto/., 2000. Parchariyanon etal., 2000.
Table 3.1: Virus strains representing the 9 sub-genotypes of CSFV used In this study.
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3.2.2 DNase digestion, nucleic acid amplification and microarray analysis
Removal of host DNA, random amplification of nucleic acid and microarray 
analysis were carried out as described in section 2 .2 .
3.2.3 CSFV genotyping probe design
A 190 nucleotide segment of the E2 region (Figure 1.17) which corresponds to 
nt 2518 to 2707 of the Alfort 187 strain (accession number X87939) was used to design 
genotyping probes for CSFV. The DNA sequences of the 190 nucleotide of the E2 region 
of all CSFV strains were compiled from the Hannover database (Dreier et al., 2007), 
and those for each sub-genotype were aligned using MegAlign software (LaserGene 
Version 7.0) to extract their consensus. The 70mer probes were designed on the 
consensus sequences as described in section 2.2.9. In addition to genotyping probes, 
the LP chip also hosts 70mer pan CSFV probes and probes to other viruses in the genus 
pestivirus (Table 3.2).
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Virus Number of probes Total probes on chip
CSFV 1.1 4 16^
CSFV 1.2 5 2 0
CSFV 1.3 5 2 0
CSFV 2.1 3 1 2
CSFV 2.2 4 16
CSFV 2.3 5 2 0
CSFV 3.1 5 2 0
CSFV 3.2 5 2 0
CSFV 3.3 5 2 0
CSFV 3.4 5 2 0
CSFV^ 16 64
BDV 466 2 8
BDV Gifhorn 2 8
BVDVl 17 6 8
BVDV 2 5 2 0
BVDV 3 5 2 0
BVDV strain 11205/98 5 2 0
BVDV strain X818 1 1 44
Pestivirus Giraffe-1 5 2 0
Pestivirus Giraffe-1 H138 5 2 0
Pestivirus PG-2 4 2 0
Pestivirus reindeer-1 5 2 0
each probe is represented in the chip with its complementary strand and in duplicate. these probes 
are hybridised to all sub-genotypes of CSFV and are adopted from Wang (2002).
Table 3.2: Pestivirus probes represented on the LP chip.
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3.2.4 Microarray chips
The LP chip was used for the CSFV genotyping experiments. BioChip version 3.1 
was used to assess the specificity of CSFV and other pestiviruses probes by testing two 
available non-pestiviruses, tick bourne encephalitis virus (TBEV) and West Nile virus 
(WNV), in the family Flaviviridae on the chip. The BioChip version 4.1 (GEO accession 
number GPL8185) that also houses probes present on the LP chip was employed to  
detect CSFV in tissues from the experimentally infected pigs. A mixed pestivirus RNA 
was also trialled on the chip to evaluate the use of the chip in detection of pestivirus 
co-infections in animals.
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3.3 Results
3.3.1 Microarray genotyping of CSFV
Nucleic acids from 10 sub-genotypes of CSFV were randomly amplified and 
hybridised on the LP chip. The chip has correctly identified and distinguished all the 10 
sub-genotypes of CSFV tested (Table 3.3). Each sub-genotype was identified by having 
the largest mean normalized logz ratio combined with the smallest and statistically 
significant p value (p < 0.01). Figure 3.1 illustrates a representative bar plot (3.1A) and 
tabulated top virus hits (3.1B) for the CSFV sub-genotype 1.1 (Alfort 187) RNA on the 
LP chip. The mean normalized logz ratios are sorted on decreasing magnitude and the 
4 viruses with the highest values are shown. CSFV sub-genotype 1.1 with the biggest 
mean normalized logz ratio, a value of 5, is on the top of the list.
TBEV and WNV, two non pestiviruses in the family Flaviviridae, were used as 
CSFV probe specificity controls. No cross hybridisation was observed with pan CSFV 
probes when TBEV and WNV were tested on the BioChip version 3.1, the only CSFV 
probes represented on the chip. On the other hand, TBEV and WNV produced the 
highest mean normalised logz ratios of 4.1 and 3.8 respectively (Table 3.4).
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B;
Virus detected by microarray No.of probes t value p value Mean log2
CSFV 1.1 8 25.10 2.1e-08 5.00
CSFV (Pan) 32 18.50 1.4e-18 4.80
CSFV 1.3 1 0 31.20 8 .6 e - l l 3.72
Pestivirus Giraffe-1 1 0 8 .1 0 l.le -05 3.70
Figure 3.1: A; Bar plot generated from CSFV sub-genotype 1.1 (Alfort 187) RNA on 
the LP chip. Each probe is indicated by a single bar and mean values have been 
averaged over replicates, normalized and clustered according to the sub-genotype on 
the X axis. The Y axis shows the raw fluorescence intensity. The probes for the CSF sub­
genotype 1.1 show the highest fluorescence intensity. Landing lights were used to 
locate the position of each sub array on the chip and to facilitate alignment of GenePix 
Array List (GAL) file for feature extraction, B; Analysis of mean fluorescence value for 
virus probes by DetectiV software using array normalisation. The normalized mean 
log2 ratios for the probes were sorted on decreasing magnitude and the four top hits 
are shown. CSFV sub-genotype 1.1 has the largest mean normalized log2 ratio (p < 
0 .0 1 ) compare to other viruses of the top hits.
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Viruses detected by the array
No. of 
probes t value p value Mean logz
Tick-borne encephalitis virus 5 56.90 2.84e-07 4.10
Louping ill virus 1 0 29.20 1.55e-10 3.65
Langat virus 5 13.80 7.98e-05 3.60
Yellow fever virus 5 3.70 l.Oe-02 2.70
Powassan virus 5 5.60 2.4e-03 2.40
Adeno-associated virus 4 5 4.60 4.9e-03 2 . 0 0
B;
Viruses detected by the array
No. of 
probes t value p value Mean log2
West Nile virus 1 0 19.50 5.56e-09 3.80
Langat virus 5 8 .1 0 6.0e-04 3.39
Tick-borne encephalitis virus 5 8.30 5.5e-04 3.37
Murray Valley encephalitis virus 5 5.80 2.1e-03 3.35
Japanese encephalitis virus 5 12.80 l.Oe-04 3.31
Yellow fever virus 5 7.030 l.Oe-03 3.00
Table 3.4: Microarray analysis o f two non pestiviruses of the family Flaviviridae on 
the BioChip version 3.1. The viruses were used as specificity controls for the CSFV 
probes. A; tick borne encephalitis virus and B; West Nile virus. In both experiments, 
the respective virus has the highest mean normalised logz ratio, values of 4.1 and 3.8 
for tick borne encephalitis and West Nile viruses respectively. No significant (p < 0.01) 
cross hybridisation was observed with the CSFV probes.
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3.3.2 Detection of CSFV from tissues of experimentally infected piglets
To assess the value of microarray in detection of CSFV at the sub-genotype 
level in an outbreak, RNA extracted from tissues of experimentally infected pigs was 
tested on the chip. The two tested viruses, sub-genotypes 2.1 (UK 2000) and 3.3 
(CBR93), were correctly identified at the sub-genotype level having the highest 
normalised mean log2 ratios of 10.9 and 4.9 respectively (Table 3.5).
A;
Viruses detected by the array
No. of 
probes t value p value
Mean
log2
CSFV 2.1 8 11.40 4.47e-06 10.90
CSFV 2.2 6 44.00 5.72e-08 10.60
CSFV 2.3 1 0 7.00 3.14e-05 8.07
Pestivirus type 2 (CSFV sub-genotypes) 1 0 4.00 1.40e-03 7.00
CSFV 1.3 1 0 4.30 9.50e-04 5.50
B;
Viruses detected by the array
No. of 
probes t value p value
Mean
log2
CSF 3.3 1 0 5.00 3.72e-04 4.90
BVD2 1 0 3.60 2.74e-03 2.89
CSF 2.2 6 3.20 1.27e-02 2.39
Pig house keeping genes 8 4.10 2.35e-03 2.30
Table 3.5: Microarray analysis of tissues from experimentaily infected piglets w ith  
CSFV sub-genotypes 2.1, UK 2000 strain (A;) and 3.3, CBR93 strain (B;) on the 
BioChip version 4.1. Both viruses were correctly identified at the sub-genotype level 
having the highest normalised mean log2 ratios of 10.9 and 4.9 respectively. This is 
considering the high genomic similarity of CSF virus sub-genotypes.
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3.3.3 Detection of multiple pestivirus infections by microarray
To assess the value of microarray in detection of pestivirus co-infections in 
pigs, an exercise was simulated by mixing equal volumes of RNA from 3 pestiviruses, 
CSFV sub-genotype 1.2, BDV S137/4 and BVDV C24V. The co-infection was 
unmistakably identified by the array and the three viruses came as top hits in the 
DetectiV analysis by having the highest normalised mean logz ratios (Table 3.6). This 
was followed by other viruses closely related to CSF, BVD and BD viruses. The 
presence of other unrelated viruses e.g. ovine papillomavirus 2  and human adenovirus 
type 31 were hot investigated further as it was outside the scope of this genotyping 
study.
99
Viruses detected by microarray No. of 
probes
t value p value Mean
Pestivirus type 2 (CSF viruses) 10 19.414 5.90E-09 12.015
CSF 1.2 10 27.898 2.37E-10 11.532
CSF 3.3 10 20.627 3.46E-09 10.862
BDV 3 10 7.919 1.20E-05 10.500
BVD 2 10 10.075 1.68E-06 10.385
Pestivirus (Pan pestivirus probes) 11 5.514 0.000128 10.330
Pestivirus type 1 (BVD viruses) 5 17.641 3.03E-05 10.219
Pestivirus Reindeer-1 15 7.378 1.73E-06 9.827
Pestivirus type 3 (BD viruses) 10 10.846 9.06E-07 9.636
CSF 1.3 10 11.699 4.78E-07 8.681
Classical swine fever virus 11 8.774 2.60E-06 8.391
House keeping genes 16 8.054 3.96E-07 7.462
CSF 1.1 8 5.411 0.00049 7.364
Ovine papillomavirus 2 5 9.097 0.00040 7.174
Bovine viral diarrhoea virus genotype 2 10 9.422 2.93E-06 6.968
CSF 3.4 10 6.371 6.47E-05 6.903
CSF 3.1 10 8.054 1.05E-05 6.724
Human adenovirus type 31 3 11.494 0.003742 6.442
CSF 3.2 10 4.336 0.0009 6.432
BVDl 34 5.212 4.93E-06 6.125
CSF 2.1 8 6.533 0.0001 5.954
Table 3.6: Simultaneous detection of multiple pestiviruses RNA by microarray. A mix
RNA containing CSFV sub-genotype 1.2, BDV and BVDV were tested on the BioChip 
version 4.1 to simulate pestivirus co-infections in pigs. The three viruses were 
correctly identified and were shown to top the table with the highest normalised 
mean logz ratios (p < 0 .0 1 ).
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3.4 Discussion
Classical swine fever is an OIE A listed highly contagious infection of the 
Suidae. The disease has the potential to cause widespread devastation in pig 
populations worldwide. The infection has been eradicated in certain countries, 
however, wild boar carriers and illegal trade of live pigs or pig products can still pose a 
threat to disease-free areas. Spread of infection through indirect transmission by 
humans, wild animals and fomites is also reported (Dewulf et al., 2001; Elbers et al., 
2001a). The disease is endemic in most parts of Asia where a greater diversity of CSFV 
strains also exist (Paton et al., 2000). The currently used live attenuated vaccine, the 
lapinised Chinese strain (C strain) has played a major role in the eradication of the 
disease particularly in Central and South America (Lepoureau, 2002; Morilla & Rosales,
2002). Flowever, the antibodies produced by the attenuated vaccine are 
indistinguishable from those produced by field strains and hence, vaccine usage is 
banned in EU countries because of international trade regulations (Moennig et al.,
2003).
The prevalent CSFV strains are moderately virulent and the clinical signs of 
disease tend to overlap with those of other viruses such as porcine circovirus 2 (Done, 
2000). The CSFV antibody detection assays, even though effective in detecting 
infection in most cases, are often prone to cross reactivity with antibodies to other 
pestiviruses. PCR has contributed significantly to CSFV diagnosis, however, PCR may 
fail to detect new and divergent CSFV isolates. Furthermore, PCR primers are 
principally designed to the conserved regions of the genome and therefore DNA
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sequences of the amplicons are of little value in phylogenetic studies and genotyping 
of the virus.
The aim of this study was to evaluate the potential of DNA microarrays as a 
tool to simultaneously detect and type CSFV isolates. FI ere, evidence is given to 
demonstrate that a microarray chip offers the ability to potentially detect and 
distinguish the recognised sub-genotypes of CSFV. This approach may in principle be 
used to diagnose and genotype CSFV isolates in pigs.
The genotyping probes were designed on the 190 bp segment of the E2 region, 
the most diverse region among CSFV genotypes (Paton et ol., 2000). The probes have 
correctly identified 10 out of 10 sub-genotypes of CSFV.
Sub-genotypes of CSFV share a close inter-genotypic homology. The sub­
genotypes also have a relatively close genetic resemblance to other viruses in the 
pestivirus genus. Nonetheless, the CSFV probes in the array have detected and 
differentiated to type the 10 CSFV sub-genotypes. The array was also successfully 
used to detect and type CSFV from experimentally infected tissues and detected 
several pestiviruses from a simulated mixed infection. The latter could prove to be 
very valuable as current diagnostic methods for pestiviruses require individual PCRs 
for each of the virus species. The chip could serve as a vital diagnostic tool in 
pestivirus endemic areas where more than one virus species or genotype might 
circulate. Moreover, automation of this technology could be beneficial for routine 
mass screening of large numbers of pig herds. This has implications for import and 
export purposes and where differentiation between vaccine and field strains is crucial.
The oligonucleotide probes used in the experiments were overlapping 70mers 
allowing a higher degree of tolerance for a target to hybridize to a non-matching but
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related sequence. This should allow hybridisation of divergent CSFV isolates and 
potential new strains of CSFV. Short sequences of specific primers often fail to amplify 
divergent isolates. The diagnostic PCR at the AFIVLA (Floffmann et al.; 2005) was 
unable to identify the divergent sub-genotype 3.4, Kanagawa isolate (McGoldrick et 
a!., 1998) whereas the LP chip has identified the virus at the sub-genotype level.
For this chip to be used as a standard diagnostic tool, extensive tests and 
probe validations have to be performed with both cell culture grown viruses and 
materials from infected animals. In conclusion, a novel diagnostic technology was 
evaluated in this study which was able to detect CSFV to genotype and to  detect 
pestiviruses from mixed viral infections.
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Chapter 4: Clinical case investigations using custom
DNA microarrays
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Case study 4.1: Nonsuppurative encephalomyelitis
outbreaks in pigs in the UK 
4.1.1 introduction
4.1.1.1 Disease history
The history and pathology of the disease was kindly provided by Dr. 
Alexandra Schock, AHVLA Lasswade. A population of approximately 35 pigs were 
affected over a period of 4-5 months from a breeding and fattening unit in 
Gloucestershire, UK. The farm comprised of about 5000 mixed age pigs on 2 
sites. The disease had occurred 3-4 weeks post weaning in eight to ten-week-old 
piglets and was considered to be self-limiting.
The affected pigs showed neurological signs typical o f spinal cord 
damage, such as hind or front leg weakness, a dog-sitting stance and the inability 
to use their hind legs. Mentation was normal and there was no evidence of gross 
joint swelling or pain in the hind legs. A strong withdrawal reflex was noted in 
both hind limbs. The affected pigs died within a few days after the onset of 
clinical signs, primarily due to inability to reach for feed and water.
During pathological examination, inflammation and unequivocal 
neuronophagia in the grey matter of the spinal cord, and to a lesser extent in the 
brain stem, were observed. Wallerian degeneration in spinal nerves was also 
noted. Histopathology has also revealed neuronal necrosis and 
lymphoplasmacytic perivascular cuffs in the central nervous system (CNS).
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4.1.1.2 Preliminary laboratory investigation
The initial laboratory investigation was conducted at the AHVLA, 
Lasswade. Cell culture, immunohistochemistry (IHC) and PCR were employed to 
investigate the cause of this outbreak. Serum from infected animals was 
inoculated into cell culture lines and immunostaining was conducted for the 
detection of porcine respiratory and reproductive syndrome virus (PRRSV), 
pestiviruses (CSFV, BVDV and BDV), porcine circovirus-2 (PCV-2), 
encephalomyocarditis virus (EMCV) and porcine parvovirus (PPV). IHC tests for 
detection of antigens for louping ill virus, porcine teschovirus (PTV), PCV-2 and 
PRRS were also performed on affected spinal cord samples. PCRs were 
performed on spinal cord samples and on cell culture material for the detection 
of Aujeszky's disease virus, PTV, CSFV, EMCV and flaviviruses. All the tests 
however, proved to be negative.
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4.1.2 Materials and methods
4.1.2.1 Sample processing and nucleic acid extraction
Samples used in the study were submitted by AHVLA Lasswade. The 
spinal cord samples (cervical, thoracic and lumbar) from an affected animal were 
homogenized in Griffin's tubes and resuspended in 300 jul of distilled water. The 
homogenized material was centrifuged at 6000 xg for 5 minutes and the 
supernatant was rescued and centrifuged through 0.22 pM filter columns (Spin- 
X, Corning, USA) at 10,000 xg for 10-20 minutes (until all, or most of the 
homogenate flowed through). Genomic DNA and RNA in the sample were 
digested with a cocktail of nucleases prior to viral nucleic acid extraction. In brief, 
20 pi o f lOx amplification grade DNase buffer (Invitrogen), 7 pi Omnicleave 
Endonuclease (200 u/pl. Epicentre Biotechnologies, Wisconsin, USA) and 7 pi 
Riboshredder RNase blend (1 u/pl) were added to 166 pi of the filtered 
homogenate. The digestion was carried out at 37 °C for 2 hours on a 
thermomixer (Eppendorf) with a pre-programmed mixing at 500 rpm for 15 
seconds at 3 minute intervals. The RNA extraction was performed with TRIzol 
(Invitrogen, USA) according to the manufacturer's protocol, and the pellet was 
resuspended in 16 pi distilled water. Remaining DNA contaminants were further 
removed with 2 pi amplification grade DNase I (1 u/pl, Invitrogen) as described in 
section 2.2.2.
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4.1.2.2 Microarray assay
The cDNA and second strand synthesis, sequence independent 
amplification, labelling reaction, and microarray (including hybridisation, 
washing, scanning and data analysis) were carried out as described in section 2.2.
4.1.2.3 Confirmatory PCR to verify microarray observation
The randomly amplified PCR products were further amplified by PCR with 
forward; 5 '-TC A GTACCA GTAGGT AG G -3'and reverse; 5 '-TG T GCC AAT GAT 
ATG TTC -  3' primers using Qiagen Fast Cycling PCR kit (Qiagen). The forward and 
reverse primers were corresponding to nucleotide 7338-7355 and 7437-7420 on 
the porcine sapelovirus (PSV) -V13 strain (formerly porcine enterovirus 8) 
genome, accession number AF406813, respectively. Each PCR reaction was 
comprised of 10 pi Qiagen Fast Cycling PCR master mix (2x), 1 pi of each of 20 
pM forward and reverse primers and 2 pi of template and topped to 20 pi with 
FI2O. The PCR reaction, which amplifies a 100 bp DNA segment of 3' UTR, were 
performed at 96 °C for 5 minutes followed by 35 cycles of 96 °C for 5 seconds, 50 
°C for 5 seconds, 72 °C for 1 minute and a final elongation step of 72 °C for 5 
minutes. The amplified products were analysed by 1.5 % standard agarose gel 
electrophoresis. The amplicons of the expected size were excised and purified 
with the MinElute gel extraction kit (Qiagen). Sequencing reactions were 
performed using a BigDye Terminator v3.1 Cycle Sequencing kit (Applied 
Biosystems) as per the manufacturer's instructions and the labelled products
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were sequenced using ABI Prism Sequence Detection System (Applied 
Biosystems) by the central sequencing unit, AHVLA Weybridge.
4.1.2.4 Porcine sapelovirus (PSV) 3D polymerase region 
amplification and phylogenetic analysis
I
The published sequence of the PSV-V13 was used to design overlapping 
primers to amplify a 1521 bp genomic region that covers the 3D polymerase 
encoding region (Table 4.1). The polymerase gene has often been used for 
phylogenetic analysis of picornaviruses (Knowles, 2008). The 1521 bp region 
corresponds to nt 5858 - 7344 of the PSV-V13 genome. The PCRs were 
performed on the cDNA using the Fast Cycling PCR kit as mentioned above. The 
PCR conditions comprised of a 96 °C initial dénaturation step for 5 minutes, 
followed by a 35-cycle amplification of 96 °C for 10 seconds, 55 °C for 10 seconds 
and 72 °C for 2 minutes, with a final extension of 2 minutes at 72 °C. The 
amplified products were analysed by 1.5 % standard agarose gel electrophoresis 
and the amplicons of the expected size were excised and prepared for 
sequencing as described in section 4.I.2.3. PCR and sequencing were repeated 
where necessary to obtain an unambiguous DNA sequence reads. The sequence 
was submitted to the GenBank under accession number JN860928. For 
phylogenetic analysis, sequences from the 3D polymerase region were 
assembled and aligned using EditSeq, SeqMan, and MegAlign softwares 
(LaserGene version 7.0). The sequences used for comparison were obtained from 
GenBank. A phylogenetic tree was constructed using PHYLIP software version
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3.68 (Felsenstein, 2003). The confidence values in tree groupings were calculated 
using bootstrapping (2000 replicates).
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Primer
No.
Forward primer 
(S'-3 1
Reverse primer 
(S'-3 1
Size
(bp)
1 ATC CAT GAG CGC GAG ATA G 
(5858-5876)^
AGA TGG GGT GAT TGA AAT GTA G 
(6158-6137)
331
2 AAG G IG  GGA GAA T G I GGA GG 
(5904-5923)
GAA AAA GTG AAG GGT GGA AAG G 
(6104-6083)
201
3 AAT AGA GAG GAT GAA AGG GG 
(6042-6061)
AGT GGG ATA GAG GAG ATG G 
(6330-6312)
289
4 GGT TTG GAG GGT TGA GTT TTT G 
(6082-6103)
AGT GGG ATA GAG GAG ATG G 
(6329-6308)
248
5 AGA AAG AGG TGA TTG GAG GG 
(6400-6419)
AGG AAT GTG AGG AGG AAA G 
(6699-6681)
300
6 AGA GAA GGG TGA AAG ATG GG 
(6946-6965)
GTT GGT GTA ATG AAA AGG AGA G 
(6728-6707)
219
7 AGA GAA GGG TGA AAG ATG GG 
(6510-6529)
AAG GAA AGA GGT GAT AAG GTG 
(6757-6737)
248
8 GGT GAA AGT TTG GTG GTG AG 
(7406-7425)
GGA ATT GAT AGG GAT AGG GAA G 
(7038-7017)
369
9 GTG TGG TTT TGA TTA GAG GAA G 
(6708-6729)
GGA ATT GAT AGG GAT AGG GAA G 
(7038-7017)
331
10 GTG TGG TTT TGA TTA GAG GAA G 
(6708-6729)
GAT GGG AAA TAG AGG ATG AGA G 
(7186-7165)
479
11 GTG TGG TTT TGA TTA GAG GAA G 
(6708-6729)
GGT GAA AGG ATA AGT GTT TGG G 
(7058-7037)
351
12 GGG AGG AGA TAA GTG AAG AAG 
(7088-7108)
GGA GAA GTG TTG ATA AAG GTG G 
(7319-7298)
232
13 GAT AAG GGG AGG AGA TAA GTG 
(7082-7102)
AGG TGG TAA TAT GAG AGG GG 
(7372-7353)
291
' Position on the PSV-V13 genome
Table 4.1: Tiling primers designed on the 1.5 kb region covering the 3D 
polymerase sequence of PSV-V13. The primers were used in PCR and sequencing 
to characterize the virus detected in the spinal cord of one of the piglets with 
non-suppurative encephalomyelitis.
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4.1.3 Results
4.1.3.1 Microarray analysis of the spinal cord samples
Nucleic acids extracted from the homogenised spinal cord samples 
(cervical, thoracic and lumbar) of one of the affected piglets were amplified, 
labelled and hybridised on the BioChip version 3.1. Microarray analysis on 
cervical, thoracic and lumbar spinal cord sample showed the presence of a virus 
closely related to porcine sapelovirus (PSV) (Table 4.2), an entero-like virus in the 
Picornaviridoe family. In cervical sample (Table 4.2A) probes to the porcine 
sapelovirus had the highest mean fluorescence logz ratio and p = 0.005 when the 
fluorescence intensities were analysed by the DetectiV software. Mean 
fluorescence intensity for the porcine sapelovirus probes was approximately 57 
times higher than that for the unrelated control sample. It is highly likely that the 
signal for infectious bursal disease virus. Starry flounder rhabdovirus and bovine 
herpesvirus 1 are either non specific considering the disparate animal species or 
with an insignificant mean value and p < 0.01. Therefore, these viruses were not 
investigated further. The involvement of encephalomyocarditis virus (EMCV) and 
pestiviruses was already ruled out in preliminary laboratory investigation. 
However, the possibility also existed that the EMCV, another member of 
Picornaviridoe, signal was due to the genome sequence similarity with PSV. In 
the thoracic (Table 4.2B) and lumbar samples (Table 4.2C), PSV was one of the 
top virus hits followed by other members of Picornaviridae with significant p 
values (p < 0.01). In thoracic sample (Table 4.2B) rather high normalised mean 
log2 values of 4.4 and 3.1 for swine vesicular disease virus, enteroviruses and 
kobuviruses, other members of the family Picornaviridae, further endorses the
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proposed involvement of a picornavirus in the outbreak. The sample was not 
investigated for presence of parvoviruses as it was expected that other 
mammalian parvovirus probes should have appeared on top of the virus lists. In 
the microarray analysis on the lumbar sample (Table 4.2C) only the signal for PSV 
and ovine adenovirus was significantly (p < 0.01) greater than those from control 
sample. Ovine adenovirus has only been associated with mild respiratory and 
enteric diseases (Pommer & Schamber, 1991).
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A;
Viruses detected by microarray No. of probes t value p value Mean
Porcine sapelovirus 10 3.03 0.007 5.40
Infectious bursal disease virus 10 3.24 0.005 3.70
Starry flounder rhabdovirus 9 2.37 0.02246 3.60
Bovine herpesvirus 1 17 3.26 0.02243 3.20
Encephalomyocarditis virus 10 2.73 0.011 3.16
Pestivirus type 3 10 2.39 0.210 3.00
B;
Viruses detected by microarray No. of probes t value p value Mean
Swine vesicular Disease 3 4.82 0.020 4.41
Parvovirus (pan-parvovirus) 3 28.48 0.0006 4.40
Enterovirus (pan-enterovirus) 8 5.37 0.0005 4.04
Porcine sapelovirus 10 3.84 0.0019 3.51
kobuvirus 14 5.76 3.26e-05 3.14
C;
Viruses detected by microarray
No. of 
probes
t value p value Mean
Ovine lentivirus 5 3.09 0.018 6.73
Epizootic haemorrhagic Disease virus 3 3.12 0.044 6.56
Porcine sapelovirus 10 3.06 0.006 5.72
Ovine adenovirus 10 3.25 0.004 5.71
Avian myelocytomatosis virus 5 2.30 0.041 5.44
Table 4.2: DetectiV software analysis of the microarray output performed on 
the cervical (A;), thoracic (B;) and lumbar (C;) spinal cord sample from an 
affected piglet w ith non suppurative encephalomyelitis. The tables show the 5- 
6 top virus hits, which are sorted by decreasing magnitude of normalised mean 
log2 ratios of feature intensities. The porcine sapelovirus was considered as the 
likely candidate virus associated with the non-suppurative encephalomyelitis.
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4.1.3.2 PCR to evaluate microarray observations
To establish the validity of the microarray findings, a primer-specific PCR 
was performed on the randomly amplified PCR products and the amplicons were 
analysed by DNA sequencing. The specific primers for the PCR were designed on 
a 100 nt stretch at the 3' UTR of the PSV-V13 genome where the two 70mer 
probes with the highest fluorescence intensity on the array were located. The 
PCRs produced amplicons of the expected size (Figure 4.1) and DNA sequence of 
the amplicons (Appendix A) have showed the highest homology to the PSV-V13.
-► 500 bp
■> 100 bp
C L T 100 bp
Ladder (Promega)
Figure 4.1: Agarose gel electrophoresis of the PCR products obtained with the 
primers designed on two of the probe nucleotide sequences. An expected, DNA 
band size of 100 bp was observed in the cervical (C), lumbar (L) and thoracic (T) 
samples of the spinal cord from one of the affected piglets. The PCR primers 
were designed on a region of PSV-V13 where the two probes with the highest 
fluorescence intensity are located. Templates for the PCR were randomly 
amplified products, which tested positive by microarray.
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4.1.3.3 The 3D polymerase region PCR and phylogenetic analysis
In an attempt to phylogenetically characterize the porcine sapelo-like 
virus, tentatively named PSV-G5 strain, detected in the current study, tiling 
primers were designed to amplify a 1.5 kb region of the viral genome including 
the 3D polymerase region (Krumbholz et al., 2002; Chun-Hsien & Hsiang-Jung, 
2007). PCRs were performed on the cDNA (Figure 4.2) and all the primer pairs 
produced DNA bands of the expected size.
► 500 bp
100 bp
lOObp 1 2 3 4 5 6 7 8 9 10 11 12 13 lOObp
Ladder Ladder (Promega)
Figure 4.2: PCR amplicons using the tiling primers designed on the 1.5 kb region 
of the 3D polymerase gene of PSV-V13. The numbering for the amplicons 
corresponds to those for the primers in Table 4.1. The PCRs were performed on 
the cDNA produced by random primer A as described in section 2.2.3.
The 802 bp nucleotide sequence of the 3D polymerase region of the PSV- 
G5 were compared with those of viruses in the Picornaviridae. PSV-G5 shared the 
highest sequence similarity in the 802 bp DNA segment with those of virus 
species in the Sapelovirus genus. The nucleotide sequence similarity was 91-93 
%, 65 % and 61 % to porcine, simian and avian sapeloviruses, respectively. PSV- 
G5 shared 50-51 % homology to virus species in the Teschovirus genus and 57-60
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% to porcine virus species in the Enterovirus genus in this region. The nucleotide 
homology of other virus species in Picornaviridae to that of the PSV-G5 ranged 
from 41 % to 62 %. To determine the relationship between PSV-G5 and other 
members of the Picornaviridae, phylogenetic analysis of the 802 nucleotide 
region of the 3D polymerase region was performed. The analysis clustered PSV- 
G5 with other porcine, simian and avian sapeloviruses (Figure 43).
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Figure 4.3: Phylogenetic analysis of the 3D polymerase region of the PSV-G5. The phylogenetic 
tree was constructed by PHYLIP 3.68 software and the confidence levels were calculated using 
bootstrapping (2000 replicates). Only the bootstrap percentages above 50 are shown on the tree. 
Accession number for each virus strain is shown on the tree by the virus names.
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4.1.4 Discussion
In the 8th report of the International Committee on Taxonomy of Viruses 
porcine entero-like viruses of the Picornaviridae family are classified into three 
genera; Teschovirus, Sapelovirus and Enterovirus (Fauquet et al., 2005).
Viruses in these three genera are non-enveloped and have a positive 
sense, single stranded RNA genome with icosahedral capsid symmetry. The 
genome is about 7.5-8.3 kilobases in size. The viral capsid is about 80 nm in 
diameter and is composed of a densely packed icosahedral arrangement of 60 
protomers. Each protomer comprises of 4 viral capsid proteins VPl, VP2, VP3 and 
VP4. The first 3 proteins (VP 1-3) are located externally whereas the VP4 is 
present internally, lining the interior side of the capsid. The genome contains a 
single open reading frame flanked by a 5' viral protein (VPg) and a 3' 
polyadenylated tail. The single open reading frame codes for a single polyprotein 
that is proteolytically cleaved to produce structural proteins (VPl-4) and non- 
structural proteins. The 5' VPg is hypothesized to play an important role in 
packaging the viral genome into the capsid and initiating the viral RNA synthesis 
(Patrick et al., 2002). The 3' polyadenylated tail enhances the infectivity of the 
viral RNA.
Historically, viruses in the Teschovirus genus, formerly porcine 
enterovirus (PEV) 1-7 and 11-13 are responsible for porcine encephalomyelitis 
(Madr, 2000). Teschovirus encephalomyelitis was first described as a particularly 
virulent, highly fatal encephalomyelitis of pigs known as Teschen disease (or 
enterovirus encephalomyelitis) (Trefny, 1930). It is caused by strains of porcine 
teschovirus serotype 1 (PTV-1). Less severe forms of the disease were first
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recognised in the United Kingdom, where it was called Talfan disease, and in 
mainland Europe it was referred to as poliomyelitis suum or benign enzootic 
paresis (Madr, 2000). The milder form of the disease is caused by other PTV 
serotypes, including PTV-2-6, 9 and 10. The disease was first described in 
Teschen, Czech Republic in 1929. During the 1940s and 1950s PTV-1 caused 
serious losses in European countries and spread to other continents. The clinical 
disease is now rare and has not been reported in Western Europe since 1980. 
However, there has been serological evidence that virus variants, which are not 
pathogenic or are of low pathogenicity, circulate in pig populations.
Porcine sapelovirus [sapelo; simian, avian and porcine entero-like virus], 
formerly porcine enterovirus 8 (PEV-8), was first isolated from faeces of healthy 
pigs in the UK (Betts, 1960). Until recently, the viruses were classified under the 
Enterovirus genus. However, distinct genomic features, presence of a leader 
polypeptide, the internal ribosome entry site (1RES) in the 5' UTR and distinctive 
sequences for non-structural proteins 2A, 28 and 3A, has prompted the 
reclassification of these viruses into the new genus Sapelovirus. Porcine 
enteroviruses, which included porcine sapeloviruses until recently, have been 
reclassified several times since first reported hence, the exact classification of 
these viruses in many of the early papers is ambiguous.
Porcine sapelovirus infections are most frequently subclinical, however, 
PEV-8 has been associated with diarrhoea, pneumonia and reproductive 
disorders in natural or experimental infections (Knowles, 2008). Nonetheless, the 
role of porcine sapeloviruses as enteric and respiratory pathogens and in 
particular, as a cause of polioencephalitis is less clear. The viruses have
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frequently been isolated from faeces of piglets with diarrhoea but they can also 
readily be isolated from normal piglets. It is also probable that alone they rarely 
cause clinical signs of respiratory disease. Porcine sapeloviruses have also been 
isolated in association with stillbirth, mummified foetuses, embryonic death and 
infertility and the disease can be induced experimentally (Fenner, 1993). There 
has been no report so far on the association of porcine sapeloviruses with 
encephalitis in pigs. In addition, sapeloviruses from other species have not been 
directly linked to encephalomyelitis.
Porcine sapeloviruses were first reported in the UK in 1960 from faeces of 
healthy pigs (Betts, 1960). The virus strain in this report, PSV-G5, is the first 
reported neurotropic porcine sapelovirus in the world. Presence of the virus in 
the spinal cord argues against accidental infection, however, further tests such as 
in situ IHC or hybridisation and virus isolation in cell culture are required to 
establish a causal association.
Detection of a PSV half a century after its first report emphasizes the 
merit of microarray analysis in identification of re-emerging viruses. The 
aetiology of a significant proportion of cases of encephalitis still remains 
undetermined in both human and animals (Studahl et a!., 1998; Theil et oL, 
1998). It is likely that recent developments in multiplex and high throughput 
assays would contribute to aetiological resolutions of non-suppurative 
encephalitis caused by infectious agents in both species.
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Case study 4.2: Diarrhoea and high mortality in goslings 
from the UK in 2008, suspected goose parvovirus 
4.2.1 Introduction
4.2.1.1 Disease history
The disease history, clinical observations and pathology of the outbreaks 
described here were reported by Dr. Richard Irvine, AHVLA Weybridge. UK. The 
outbreak was in a flock of 185 birds with a recorded mortality rate as high as 75 
%. The birds appeared symptomatic from 5-30 days and most severe losses were 
recorded from day 14 onwards. The affected flock was goslings imported from 
Denmark. Clinical signs were primarily diarrhoea, bilateral periocular and 
palpebral swelling with semi-mucoid oculonasal discharge. Presence of oral 
necrosis and a diphtheritic psuedomembrane in the .buccal cavity was 
characteristically observed in all the affected birds. Signs of lethargy, anorexia, 
ataxia, dysphagia and weight loss were also evident. Gross pathology consisted 
of ulcerated tongue and oropharynx, fibrinous pericarditis and perihepatitis, 
diffuse fibrinous ascites, pallor of myocardium, pulmonary edema and ascetic 
fluid accumulation in the abdominal coelomic cavities. There were also scant 
ingesta in the enteric tract, catarrhal enteropathy and large intestinal contents of 
variable consistency. Generalized visceral congestion and organomegaly was also 
noticeable in some birds. Histopathological examination revealed a chronic 
multifocal cardiomyopathy.
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4.2.1.2 Preliminary investigation
The preliminary investigation to isolate a virus in cell culture, 
embryonated duck, goose eggs and goose embryo fibroblasts was attempted by 
Avian Virology, AHVLA but failed to recover any virus. No further tests were 
performed on the samples at this stage.
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4.2.2 Materials and methods
4.2.2.1 Sample preparation and nucleic acid extraction
The clinical samples were post mortem submits from Devon, UK. The 
samples of liver, heart, kidney and spleen from the affected bird were 
homogenized in Griffin's tubes and resuspended in 300 pi of distilled water. The 
homogenized materials were processed for microarray as described in section 
4 .I.2 .I. RNA extraction was performed with TRIzol (Invitrogen, USA) according to 
the manufacturer's protocol and the pellet was resuspended in 16 pi distilled 
water.
4.2.2 2 Microarray analysis
The cDNA, second strand synthesis, sequence independent amplification, 
labelling, hybridisation and data analysis were carried out as described in section 
2.2.
4.2.2.S PCR to validate microarray output
The random amplified products which tested positive on the microarray 
were used as templates in two goose parvovirus specific PCRs. The first PCR 
targeted a 203 bp of the inverted terminal repeats (ITRs) and was carried out 
with the forward primer: 5' -  CTC ATT GGA GGG TTC GTT CGT TCG AA -  3' 
(nucleotide 1-25 and 5080-5105) and reverse primer: 5' -  GCA TGC GCG TGG TCA 
ACC TAA CAG CCG GAA A -  3' [nucleotide 203-173 and 4933-4903; GPV 
(accession number NC_001701)] (Shien et al., 2008). The PCR was carried out
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using the Fast Cycling PCR kit (Qiagen), as described in section 4.1.2.3, at 95 °C 
for 4 minutes followed by 35 cycles of 95 °C for 1 minute, 55 °C for 1 minute, 72 
°C for 1 minute, and a final step of 72 °C for 2 minutes. The second PCR was 
performed with forward primer; 5'- AGA AAA CCC CAA CGA AAA GA -  3' 
(nucleotide 2562-2581) and reverse primer; 5' -  CTC CGC TTC CTC CCT CTG -  3' 
[nucleotide 3054-3037; GPV (accession number NC_001701)] (Shien et al., 2008) 
as described above. The expected amplicon size is 492 bp. The amplified 
products of the PCRs were analysed by 1.5 % agarose gel electrophoresis, the 
amplicons of expected size were excised and DNA was recovered by MinElute gel 
extraction kit (Qiagen). Sequencing of the amplicons was carried out as described 
in section 4.I.2.3.
4.2.2.4 Amplification and phylogenetic analysis
In order to phylogenetically characterize the goose parvovirus detected in 
the study, PCR was performed with forward AL18F2 5' -CCG GGT TGC AGG AGG 
TAC- 3' (nucleotide 3965-3982) and reverse AL18R2 5' -AGC TAC AAC AAC CAC 
ATC- 3' [nucleotide 3194-3177; GPV (accession number NC_001701)] primers 
(Limn et a!., 1996) on the cDNA using Fast Cycling PCR kit (Qiagen). The primers 
target an 800 bp region towards the 3' end of the genome which comprises 
fragment A, often used in phylogenetic analysis (Tatar-Kis et a!., 2004). The PCR 
reaction was performed as described in section 4.1.2.3 at 95 °C for 4 minutes 
followed by 35 cycles of 95 °C for 1 minute, 48 °C for 1 minute, 72 °C for 1 minute 
and a final step of 72 °C for 2 minutes. The amplified products were prepared for 
sequencing as described in section 4.I.2.3. PCR and sequencing were repeated
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where necessary to obtain an unambiguous DNA read. For phylogenetic analysis, 
the published sequences of the goose parvovirus fragment A (Table 4.3) were 
assembled and analysed using EditSeq, SeqMan and MegAlign softwares 
(LaserGene 7.0). A Phylogenetic tree was constructed using neighbour joining 
method of the PHYLIP 3.68 software and confidence values in tree groupings 
were calculated using bootstrapping (2000 replicates).
GPV strains Year of isolation
Geographic
origin
Pathogenicity References
Pusztafoldvar/79 1979 Hungary Low (Tatar-Kis e ta l. , 2004)
Csongrad/80 1980 Hungary Low (Tatar-Kis e t  a i , 2004)
Bocsa/98 1998 Hungary Pathogenic (Tatar-Kis e t  a i , 2004)
Bocsa/99 1999 Hungary Pathogenic (Tatar-Kis e ta l. , 2004)
Bocsa/00 2000 Hungary Pathogenic (Tatar-Kis e t  a!., 2004)
Baiastya/OO 2000 Hungary Pathogenic (Tatar-Kis e t  a!., 2004)
D 146 /02 2002 France M oderate (Tatar-Kis e t a!., 2004)
GPV486 NA^ UK Vaccine (Tatar-Kis e t  a l., 2004)
B42 NA Hungary Vaccine (Tatar-Kis e t  a l., 2004)
LB 1969 Hungary Pathogenic (Kisary &  Derzsy, 1975)
Hoekstra NA France Vaccine (Tatar-Kis e t  a l., 2004)
TWL^ NA Taiwan NA NA
B 1960s Hungary Pathogenic (Zadori e t a l., 1995)
92217 1992 Taiwan Pathogenic (Chang e t  a l., 2000)
8324 NA France NA (Chang e t  a l., 2000)
SHM 319 1960s Germany Pathogenic (Brown e t a l., 1995)
82322 1982 Taiwan Pathogenic (Chang e t  a l., 2000)
991222 1999 Taiwan Pathogenic (Chang e t a l., 2000)
981218 1998 Taiwan Pathogenic (Chang e t  a l., 2000)
C H /H U 0 2/0 8^ 2008 China NA NA
V G 32/1 2008 Taiwan Vaccine (Shien e t a l., 2008)
; not available 
^  accession number AY496892.1 
^  accession number FJ240171.1
Table 4.3: List of goose parvovirus (GPV) isolates used in the phylogenetic tree 
construction to  characterize the GPV detected in one of the affected goslings.
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4.2.3 Results
4.2.3.1 Microarray analysis of the goose samples
Nucleic acids extracted from the liver, heart, kidney and spleen tissues of 
an affected gosling was amplified, labelled and hybridised on to the BioChip 
version 3.1. The microarray analysis demonstrated the presence of goose 
parvovirus (GPV), tentatively named GPV_Devon/08, in all the samples. Analysis 
of the feature fluorescence intensities by the DetectiV software of liver, heart, 
kidney and spleen of the affected bird is given in Table 4.4. The probes for GPV 
on the array produced the highest mean logz value when normalised against 
those of an unrelated control sample (p = 2.5e-05). A relatively high normalised 
mean logi ratio for other parvovirus, adeno-associated viruses (members of 
Parvoviridae family), provides further evidence on correct recognition of GPV by 
the microarray.
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A;
Viruses detected by 
microarray
No. of probes t value p value Mean
Goose parvovirus 5 18.40 2.5e-05 5.53
Adeno-associated virus 4 5 11.05 0.00019 3.60
Adeno-associated 3B 5 5.57 0.002 3.52
Adeno-associated 3 5 4.20 0.006 3.31
B;
Viruses detected by 
microarray
No. of probes t value p value Mean
Goose parvovirus 5 11.10 2.7e-04 5.35
Adeno-associated virus 4 5 8.10 0.00073 3.30
Adeno-associated 3B 5 4.01 0.011 3.10
Adeno-associated 3 5 3.03 0.019 3.02
C;
Viruses detected by 
microarray
No. of probes t value p value Mean
Goose parvovirus 5 12.10 1.3e-04 4.70
Adeno-associated virus 4 5 6.70 0.001 2.78
Adeno-associated 3B 5 3.61 0.011 2.71
Adeno-associated 3 5 2.83 0.022 2.50
D;
Viruses detected by 
microarray
No. of probes t value p value Mean
Goose parvovirus 5 18.40 2.5e-05 5.51
Adeno-associated virus 4 5 11.05 0.00019 3.60
Adeno-associated 3B 5 5.50 0.0025 3.53
Adeno-associated 3 5 4.21 0.0067 3.32
Table 4.4: DetectiV analysis of the microarray output from liver (A;), heart (B;), 
kidney (C;) and spleen (D;) samples of the affected gosling. The table shows the 
first 4 top virus hits, the probes of viruses with the highest normalised mean logz 
ratios of feature intensities. The test identified goose parvovirus as the possible 
candidate virus to be associated with the outbreak.
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4.2.3 2 Validation of microarray output by PCR
Two confirmatory PCRs were performed on the randomly amplified 
products to validate the microarray output. Primers for the first PCR target the 
hairpin repeats or ITRs present at the 5' and 3' terminal regions of the genome. 
The second PCR primers are to the fragment B region present on the VPl coding 
sequence. The two primer sets produced the expected DNA bands of 203 bp and 
492 bp in most of the tissues tested (Figure 4.4). The liver sample did not 
produce a PCR product when tested with the first set of primers. All PCR 
products were subjected to sequencing for verification.
►  5 00  bp
► 2 00  bp
L H K S lOObp (Promega)
Fragment B
Figure 4.4: An agarose gel eletrophoresis of the PCR products from liver (L), 
heart (H), kidney (K) and spleen (S) of the affected gosling. The PCRs were to 
validate microarray results and templates were the randomly amplified products 
which tested positive on the microarray. The first PCR amplified a 203 bp 
terminal repeats at the 3' and 5' end of goose parvovirus genome whilst the 
second PCR amplified the 492 bp fragment B segment on the VPl gene.
4.2.3.B GPV PCR and phylogenetic analysis
Fragment A of the VP3 capsid protein gene in the genome of goose
parvoviruses has routinely been used for phylogenetic analysis. The fragment
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spans from nucleotide 3172 to 3712 on VP3 of GPV, SHM 319 strain (accession 
number U34761.1) (Zadori et al., 1995). Primers AL18F2 and AL18R2 which flank 
fragment A are designed on VPl and VP2 coding regions of the GPV genome, 
which are relatively conserved among the GPV strains (Tatar-Kis et al., 2004). The 
primers produced DNA bands of expected size in all the samples tested and 
nucleotide sequence (Appendix B) of the bands were GPV specific.
-► 8 0 0  b p
-► 5 00  b p
lOObp ladder (Promega)
Figure 4.5: Agarose gel electrophoresis of the amplicons obtained In PCR with 
primer pair which flanks the fragment A of GPV genome. The template for the 
PCR was the cDNA convert of the nucleic acid extracted from liver (L), heart (H), 
kidney (K) and spleen (S) of the affected gosling. The PCR amplified an 800 bp 
segment which includes the fragment A region.
Phylogenetic analysis of the fragment A of GPV detected in the study, 
revealed a very high nucleotide sequence homology with those of the UK and 
Hungarian strains (Figure 4.6). The virus had 98.9 % nucleotide homology to the 
UK strain whilst the nucleotide homology to the Hungarian strains ranged from 
98.1 -  98.9 %. Two French strains (Hoekstra and 83-24) and one Taiwanese strain 
(92-217) of GPV also shared rather high percentage of homology, 97 % and 98 %, 
respectively. Other GPV strains reported from Asia, Europe and North America
have showed a percentage of nucleotide homology between 94.4 -  96.5 %.
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Figure 4.6: Phylogenetic analysis of GPV fragment A region of the virus 
detected from the affected gosling (In red) w ith those of other goose 
parvoviruses In GenBank. Muscovy duck parvovirus (MDPV, accession number 
NC_006147) was used as an out-group. The phylogenetic tree was constructed 
by PHYLIP 3.68 software and the confidence levels were calculated using 
bootstrapping (2000 replicates). Only the bootstrapping percentages above 50 
are shown on the tree.
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4.2.4 Discussion
Clinical samples of liver, heart, kidney and spleen from the suspected GPV 
case were processed for microarray investigation. Statistical analysis of 
microarray output followed by primer specific PCRs has confirmed presence of a 
GPV in all the samples. The GPV is a member of the family Parvoviridae. GPV 
genome is a linear, single stranded DNA of both senses which is packed in an 
icosahedral capsid structure. The genome is 5106 nucleotides in length and 
contains a long protein-coding region flanked by two inverted terminal repeats 
of 444 nucleotides. The long protein-coding region has two open reading frames 
(ORFs) encoding the non-structural proteins (NSPs) and structural proteins VPl, 
VP2 and VP3 (Zadori et al., 1995). The genes encoding NSPs and viral structural 
proteins are located towards the 5' and 3' ends of the genome, respectively. The 
NS proteins play a role in virus replication and the two structural proteins (VP2 
and 3) form the outer surface of the viral capsid. The three genes VPl, VP2 and 
VP3 encoding the three structural proteins are present in a basket structure. As a 
result, the three structural proteins (VPl, 2 and 3) share the same sequence and 
stop codon but translation of the mRNA is initiated at different start codons 
(Tatar-Kis etal., 2004).
GPV causes Derzsy's disease; also called goose hepatitis, goose plague 
and viral enteritis, in geese and Muscovy ducks (Derzsy, 1967; Gough et al., 
1981). The infection is age dependent and mortality rates may reach 100 % in 
birds less than seven days old. The birds usually develop progressive resistance 
during growth and as a result, the percentage losses diminish by the age of 4-6
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weeks. The severity of infection in neonatal birds depends on the levels of 
maternally derived antibody. In mature birds GPV is subclinical and latent (Gough 
et o/., 1981; Zadori et o/., 1995).
Spread of GPV infection can occur via both horizontal and vertical 
transmission modes. Horizontal transmission occurs when the infected birds, 
which usually excrete high loads of virus, come in contact with uninfected and 
unvaccinated birds. Vertical transmission occurs via contaminated eggs. High 
levels of mortality are recorded during incubation of eggs and at birth of 
neonatal birds. Spread of infection at hatching stage is also rather high (Kisary, 
1977).
GPV was first reported in Great Britain in 1981 when it was first 
introduced into the country in imported eggs (Gough et al., 1981). However, 
there was no report of the infection till 2004. GPV outbreaks were reported in 5 
gosling farms in the UK in 2004 (Irvine et al., 2008). The mortality rate recorded 
in these outbreaks was 50-70 %, in particular, higher in goslings under the age of 
1-2 weeks. The source of the infection was traced to one of the affected breeder 
farms, which had supplied the birds to the rest of the four affected sites. The 
second case was in 2005 at a single site. The goslings affected were the offspring 
of birds retained from one of the affected farms in 2004. Similarly, there was an 
outbreak reported in 2007 where the breeder geese, which were bought in 2006, 
were of unknown GPV status. In 2008 there were 4 reported outbreaks. The total 
number of birds affected in this outbreak was approximately 185 and the 
mortality rate was as high as 75 %. All the goslings involved in the outbreak were 
part of a massive goose import from Denmark.
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Diagnosis of GPV can be performed by electron microscopy, PCR, ELISA 
and agar gel precipitation (AGP) test. The AGP however, cannot differentiate 
between the infected and vaccinated birds. GPV is not à notifiable disease and 
there is no prescribed official OIE diagnostic test.
The GPV identified in this investigation was grouped with isolates from 
UK (GPV486) and Hungary (Balastya/00, Bocsa/00, 99 & 99) in the phylogenetic 
analysis. There was no genomic information available from Danish strains to 
include in this comparison; therefore, no conclusion could be made on the 
source of infection. The detection of GPV in the present investigation has 
demonstrated once again the merits of the microarray as a diagnostic tool in 
disease outbreaks in diverse animal species.
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Case study 4.3: Diarrhoea and intussusception in red 
squirrels from Scotland.
4.3.1 Introduction
4.3.1.1 Disease history
Clinical specimens, disease history and pathological observations 
presented here were provided by David Everest from EM unit. Molecular 
Pathogenesis and Genetics department, AHVLA Weybridge, UK. The two cases 
studied in this project were among 78 red squirrel carcasses submitted from 
Scotland between the years 2000 to 2009 as a part of retrospective surveillance 
survey for enteric viruses within the remnant British red squirrel population. The 
first case was a juvenile female weighing 145 grams submitted in 2006 from 
Dumfries and Galloway with intussusception of the large bowel, diarrhoea and 
rectal prolapse. The second case was also a juvenile female, weighing 190 grams 
submitted in 2007 from Aberdeenshire, which had a colo-rectal intussusception 
and diarrhoea.
4.3.1.2 Preliminary investigation
Initial tests conducted by David Everest on the faeces of the two red 
squirrels using negative staining electron microscopy, revealed the presence of 
rotavirus-like particles in both animals. No other tests were conducted at this 
stage.
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4.3.2 Materials and methods
4.3.2.1 Sample preparation and nucleic acid extraction
The two squirrel faeces samples; XT854/06 and R85/07, obtained from 
the gastrointestinal tract of post mortem animals were processed for microarray 
analysis. About 200 mg of faeces was mixed with 500 pi o f distilled water and 
thoroughly homogenized using glass beads on a tabletop vortex (Vortex-2 genie. 
Scientific industries, USA). The faecal suspension was then centrifuged at 6000 xg 
for 5 minutes; the supernatant was removed and centrifuged for the second time 
for further clarification. RNA extraction was performed with TRIzol (Invitrogen, 
USA) according to the manufacturer's protocol and the nucleic acid pellet was 
resuspended in 16 pi distilled water. DNA contaminant of extracted nucleic acid 
was removed with DNase I as described in section 2.2.2.
4.5.2.2 Microarray
cDNA and second strand synthesis, amplification, labelling and 
hybridisation were carried out as described earlier in section 2.2. The BioChip 
version 4,1 was used in the study.
4.3.2.S PCR and phylogenetic analysis
Microarray observation was validated by primer specific PCR designed 
against the two probes, which produced the highest fluorescence intensity in the 
microarray. These probes were located at positions 3-73 and 900-970 on the 
outer capsid (VP7) sequence of rotavirus strain DH408, accession number
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EU839928. The primers; forward 5'- GAG AGA ATTTCC GTC TGG C-3' and reverse 
5'- CAC TTG CCA CCA TTT TTT CC -  3% targets a 922 bp segment that spans from 
nt 9 -  933 on the VP7 gene. PCRs were performed on the randomly amplified 
products using Fast Cycling PCR mix (Qiagen, USA) as described in section 4.1.2.3 
at 96 °C for 6 minutes, followed by 45 cycles of 96 “C for 30 seconds, 50 °C for 30 
seconds, 72 °C for 1 minute and a final step of 72 “C for 7 minutes. The amplified 
products were analysed by 1.5 % standard agarose gel electrophoresis, the 
amplicons of the expected size were excised and DNA extracted using the 
MinElute gel extraction kit (Qiagen). Specificity of DNA amplicons was confirmed 
by sequencing as described in section 4.I.2.3. PCR and sequencing were 
repeated on cDNA, wherever required, to obtain unambiguous DNA reads. In 
order to phylogenetically characterize the viruses detected in the study, a 
phylogenetic tree was constructed with PHYLIP version 3.68 using the neighbour- 
joining method. The statistical significance of the tree branching was also 
estimated by boot strapping (2000 replicates). A list of all rotavirus strains used 
in the phylogenetic analysis is shown in Table 4.5.
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G typ e Host Accession num ber Strain
G1 Hum an K 0 2033 V.'a
G 1 Bovine . M  9 26 51 n .a -
G2 Hum an D 5 0 1 2 4 KLIN
G3 Hum an D 8 6 2 7 1 n.a
G3 Hum an A F 26095 7 9 7 3 4 8
G3 Hum an U 0 4 3 5 0 1 0 7 e lb
G3 Bovine A F 44S 852 CP-1
G3 Porcine D 0.2 565 03 CM P 09 9
G3 Canine A F 27109 0 P.V 52 /96
G3 Rabbit A F 5 2 8 2 0 4 3 0 /9 6
G3 Sim ian X 6 6 1 5 8 S A r l l
G4 Porcine X 0 6 7 5 9 G o ttfried
G4 Hum an ABO39035 Hochi
G4 Porcine A F 1 9 2 2 6 7 ICB2185
G5 Porcine X 04 6 1 3 OSU
G6 Bovine D 1 2 7 1 0 n.a
G6 Bovine AYÜ5Ü272 n.a
G6 Bovine M 6 4 6 SO B 60
G6 Bovine X 00S 96 UK
G6 Porcine D 0 0 0 3 2 9 2 HP 113
G6 Caprine A Y 128708 n.a
G7 Chicken X 5 6 7 8 4 CH2
G7 A vian ABOSO737 n.a
GS Hum an A F 3 5 9 3 5 9 n.a
GS Hum an L2Ü882 H A L1166
GS Hum an L208S3 n.a
G9 Hum an AB 1S0969 '.V I61
G9 Porcine AB176 677 H okkaido-14
G9 Hum an L14Ü72 n.a
G9 Hum an A F 06048 7 US1205
G IO Hum an X 6 31 56 n.a
G IO Hum an D 1 4 0 3 3 M e  35
G IO Bovine EU 548 03 2 G i ra ffe /U C D /G i rR V -l /l  R L/G IO
G IO Bovine D 0 1 0 5 6 KK3
G IO Bovine M 6 4 6 7 9 B l l
G IO Bovine X 5 7 8 5 2 B223
G IO Bovine X 5 34 03 6 1A
G IO Bovine D 0 1 0 5 5 A 4 4
G l l Hum an AY773Ü 03 Dhaka6
G i l Porcine L 24163 n.a
G 12 Porcine D 0 2 0 4 7 4 3 R U 172
G 12 Hum an AB 125S53 C P1030
G1 3 Porcine D 1 3 5 4 9 L33S
G1 4 Equine D 2 5229 CH3
G 14 Equine U 0 5348 n.a
G 15 Bovine A F 23766 6 H f lS
G 16 M u rin e A F 03922 0 E D IM
G 17 T u rk e y S 5S166 T y l
G IS Porcine D S 2979 P O -13
G IS Bovine X9SS69 9 9 3 /8 3
G 1 9 , A vian AB 0S0738 C h-1
G 20 Human E U S05775 Ecu534
G 21 Bovine A B 4S6011 CACC
G 21 Bovine A B 454421 AzuK-1
G 22 A vian E U 486973 T U -0 3 V 0 0 0 2 Q 0
G 23 A vian FH 3 930 54 P h e a s a n t/H U H /2 0 0 8
G 23 Avian FN 393056 P h e a s a n t/H U N /2 0 0 8
not available
Table 4.5: List of all rotavirus strains used to phylogenetically analyse the two 
rotaviruses detected in red squirrel faecal samples in this study.
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4.3.3 Results
4.3.3.1 Microarray analysis of the red squirrel faecal samples
The nucleic acids from the two squirrel faeces samples; XT854/06 and 
R85/07 obtained from the gastrointestinal tract of post mortem animals were 
randomly amplified, labelled and hybridised on to  the BioChip version 4.1. The 
microarray analysis suggested the presence of a rotavirus in both the samples in 
line with the EM observations. The pan-rotavirus probes in the sample XT854/06 
(Table 4.6A) had the highest normalised mean log2 ratio of fluorescent intensity, 
a value of 6.2 (p = 5.11e-06). The other top virus hits were avian rotavirus PO-13 
and human rotavirus G4 with rather high mean values of 5.7 (p = 3.2e-04) and 
5.2 (p = 0.04), respectively. The signal for adeno-associated virus 6 was regarded 
as erroneous due to its cross-reactive probes as no other related parvovirus 
probes produced a significant mean value.
The viruses that were recognised by microarray for sample R85/07 (Table 
4.6B) were parvo, adeno and rotaviruses. The signal for parvo and adenoviruses 
were considered as non-specific as none of the other related viruses had a 
significant mean. Therefore, given that two rotavirus sets of probes, pan­
rotavirus and avian rotavirus, had relatively high mean values, it was concluded 
that rotavirus is the likely virus in the samples that was associated with the 
disease in the red squirrels.
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A;
Viruses detected by the array No. of probes t value p value Mean logz
Rotavirus (pan-rotavirus probes) 35 5.17 5.11e-06 6.20
Adeno-associated virus 6 5 9.70 0.000316 5.76
Avian rotavirus PO-13 12 4.20 0.0007 5.72
Human rotavirus G4 5 2.20 00.04 5.20
B;
Viruses detected by the array No. of probes tvalue p value Mean log;
Adeno-associated virus 6 5 13.00 0.0001 8.20
Duck adenovirus A 5 8.60 0.0005 7.00
Rotavirus (pan-rotavirus probes) 35 5.10 5.20e-06 6.50
Avian rotavirusTy-1 6 6.30 0.0007 6.00
Table 4.6: Microarray output of samples XT 854/06 (A;) and R85/07 (B;) 
analysed by DetectiV software. The nucleic acids from the faeces samples 
XT854/06 and R85/07 were randomly amplified, labelled and hybridised on the 
BioChip version 4.1. The table shows the first 4 top virus hits, the probes of 
viruses with the highest normalised mean log: ratios of feature intensities. The 
signal for parvo, adeno-associated virus 6, and adenoviruses was regarded as 
nonspecific as no other related parvo and adenoviruses had a significantly high 
average (p < 0.01).
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4.3.3.2 PCR validation of microarray results and phylogenetic 
analysis
In order to substantiate the microarray findings above, PCR using 
rotavirus specific primers was performed on the randomly amplified products. 
The primers were designed on the two rotavirus probes that produced the 
highest fluorescence intensity in the microarray. The PCR produced amplicons of 
922 bp (Appendix C & D) as expected in both of the samples (Figure 4.7). The 
specificity of PCR amplicons was confirmed by sequencing.
■> 900 bp
-► 500 bp
XT854/06 R85/07 100 bp ladder (Promega)
Figure 4.7: Gel electrophoresis of the amplicons obtained in PCR using a pair of 
primers designed on two of the brightest rotavirus probes on the array. The
primers were located on the outer capsid gene (VP7) of rotavirus G2 strain 
DH408 (accession number EU839928). The correct size DNA band of 922 bp was 
seen in PCR of the two squirrel samples XT854/06 and R85/07.
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The nucleotide and deduced amino acid sequence of 423 bases of 
rotaviruses VP7 coding region detected in the two squirrel faecal samples were 
compared with those of the representative rotavirus genotypes. The comparison 
revealed a genetically different rotavirus in each faecal sample (Figure 4.8 & 
Table 4.7). The virus in XT854/06 sample was clustered with rotaviruses in 
genotype 10. However, the virus from sample R85/07 did not group with any of 
the known rotavirus genotypes.
The rotavirus strain detected in sample XT854/06 showed the highest 
nucleotide and amino acid homology with those of genotype 10 virus species, 81- 
93 % and 92-95 % respectively. In particular, the virus had the highest homology 
with giraffe rotavirus, 93 % in nucleotide and 95 % in amino acid sequence. This 
rotavirus was tentatively called squirrel rotavirus XT854/06 strain.
The rotaviruses in sample R85/07, tentatively called squirrel rotavirus 
R85/07 strain, demonstrated a rather high homology to virus species classified as 
genotype 3 and 20. The nucleotide and amino acid homology recorded with 
genotype 3 was 79-83 % and 96 % respectively. With genotype 20, it recorded a 
homology of 80 % in nucleic acid and 93 % in amino acid sequences. The 
nucleotide sequence of the amplicons from the two red squirrels XT845/06 and 
R85/07 have been deposited in GenBank under accession number GQ903132 
and GQ871233 respectively.
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Figure 4.8: Phylogenetic analysis of 423 nucleotide stretch of VP7 coding region 
of the two rotavirus strains XT854/06 and R85/07 (in red) detected in the red 
squirrels faecal samples. The phylogenetic tree was constructed with PHYLIP 
version 3.68 and the confidence levels were calculated using bootstrapping 
values (2000 replicates). Only the bootstrapping percentages above 50 are 
shown on the tree.
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Genotype Host
XT854/06 R 85/07
Nucleic acid Amino acid Nucleic acid Am ino acid
G1 Hu, Bo 73 77-78 74-75 80-83
G2 Hu 70 73 73 76
G3 Hu, Bo, La, Ca, Si, Po, 75-78 83-85 79-83 91-96
G4 Hu, Po 71-73 77 75 78-80
G5 Po 73 82 77-78 88-91
G6 Bo, Po, Cap, 74-77 82-87 77-79 86-90
G7 Ch, Tur 65 68-69 65 67-68
G8 Hu, Bo 73-75 81 76-79 88-90
G9 Hu, Po 75-76 85-87 78-80 87-92
GIO Hu, Bo 81-93 92-95 78-80 85-88
G l l Hu, Po 74 83-84 79-80 91
G12 Hu, Po 71-72 78-80 72-75 83
G13 Po 75 77 78 83
G14 Eq 73 78-79 78-79 89
G15 Bo 73 78 76 82
G16 M u 73 81 76 92
G17 Tur 70 87 70 72
G18 Bo, Po 64-65 65-66 69 68
G19 Ch 67 62 68 63
G20 Hu 75 87 80 93
G21 Bo 73-74 77-78 69-70 76-77
G22 Tur 61 67 56 65
G23 Phe 62 68 62 68-69
Table 4.7: Percentage of nucleotide and amino acid sequence homology of two 
rotavirus strains XT854/06 and R85/07 in 423 nucleotide sequence of VP7 with 
those of other rotavirus G-types used in the analysis. The nucleotide and amino 
acid percentages were calculated using MegAlign software (Lasergene 8). Hu 
(human), Bo (bovine). La (laprine), Ca (canine). Si (simian), Po (porcine). Cap 
(caprine), Ch (chicken), Tur (turkey), Eq (equine). Mu (murine), Phe (pheasant). 
The genotypes with the highest percentage of homology to the two squirrel 
rotaviruses are highlighted in red.
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4.3.4 Discussion
Viruses within the genus /?otowri/s belong to the family Reoviridoe. The 
virion particles possess a three-layered protein capsid encapsulating the 11 
segments of the double stranded RNA genome (Parashar et al., 1998). The 
genome encodes six viral structural proteins (VPl-4, 6 and 7) and six non- 
structural proteins (NSl-6). Structural proteins VP4 and VP7, encoded by 
segments 4 and 9 of the viral genome respectively, constitute the outer viral 
capsid. There are seven serogroups (A-G) reported so far in the Rotavirus genus 
(Abe et a!., 2009 ; Solberg et a!., 2009; Ursu et a!., 2009). Serogroup A is the 
primary cause of rotavirus enteritis in humans and animals. Viruses in serogroup 
A are typed according to the outer capsid protein VP4 sequence (P types) and 
VP7 sequence (G type). To date, 23 G and 30 P types have been identified in 
serogroup A.
Rotavirus enteritis is one of the primary causes of diarrhoea in children 
from developing countries. Approximately 440,000 children die of rotavirus 
infections each year worldwide (Parashar et a!., 2003). The virus is transmitted 
via the faecal-oral route, as the triple layered capsid of the virion is very stable 
against the gastric acids in the stomach. The targets for the viral VP4 and VP7 
proteins are the cell receptors lining the lumen of the small intestine. Upon 
infection, the virus releases an enterotoxin, which induces diarrhoea and 
enteritis, leading to dehydration and death in severe conditions. Intussusception 
and rectal prolapse are serious complications observed in acute cases of 
rotavirus enteritis (Bines et a!., 2004). Although the faecal-oral route is the
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primary source of virus transmission, other sources such as the respiratory route 
and spread via body fluids are also recorded, but are less common. Apart from 
humans, a wide range of mammalian species and birds can be infected with 
rotaviruses.
The presence of rotaviruses in Eastern grey squirrels in Great Britain is 
already documented (Greenwood & Sanchez, 2002). Besides rotavirus, grey 
squirrels also harbour squirrel poxvirus (Rushton et al., 2006) and enteric 
adenoviruses (Sainsbury et al., 2001; Duff et al., 2007). It is hypothesized that 
grey squirrels serve as a reservoir for these viruses and transmit infections to red 
squirrels, whose numbers are rapidly declining in the UK, owning to  external 
factors like habitat loss and tough competition for food.
In an attempt to understand the prevalence and impact of rotaviruses on 
native red squirrel populations across the UK, a retrospective study was 
undertaken by AHVLA on squirrel carcasses submitted with gross post mortem 
findings suggestive of enteric infections such as diarrhoea or intestinal 
intussusceptions. The animals submitted were from Scotland, Wales, North West 
& North East England, Merseyside, and the red squirrel-only area of Jersey, the 
Isle of Wight and Brownsea Island. The two cases that were analysed in this 
study were part of this huge submission that consisted of nearly 80 cases 
collected from the year 2000-2009. These two cases were of squirrels that died 
of intestinal intussusceptions and were shown to be rotavirus positive by EM. 
Our microarray analysis on the two samples also concluded the presence of 
rotavirus in these two samples. The genetic distance between R85/07 and 
established G types of rotaviruses suggest the novelty of this new isolate.
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Phylogenetic analysis also supports the novelty of R85/07, as its branch does not 
root among its closest matches for VP7. However, designation of a new rotavirus 
types requires a complete open reading frame (ORF) sequence for VP4, VP6 and 
VP7 with a homology lower than 80 % to other established types (Matthijnssens, 
2008).
The isolate XT854/06 exhibits the highest nucleotide and amino acid 
homology to rotaviruses in genotype 10 which is also supported by phylogenetic 
analysis.
In this study, microarray analysis was successfully applied for the 
detection of squirrel rotaviruses. The microarray has also facilitated the genomic 
characterisation of the two rotaviruses as PCR primers could be designed on the 
two probes that produced highest fluorescence. This, in particular, is critical in 
investigation of viral diseases in wildlife in which little or no information available 
on diversity of their virus species.
The P and G genotypes of rotaviruses are distributed across various 
animal species. However, unusual genotypes from natural reassortments 
between human and animal rotaviruses have been emerging especially in cattle 
and pigs (Martella, 2006). This indicates that animal rotaviruses are regarded as a 
potential reservoir for human rotaviruses. Monitoring of newly emerging 
rotaviruses in animals, and in particular in wildlife, may therefore be important 
for the control of rotavirus infections in both animals and humans.
Greenwood and Sanchez (2002) described a limited study of grey 
squirrels, in which they demonstrated a serological response to laboratory 
strains of murine rotavirus. The possibility exists that, like poxvirus, grey squirrels
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serve as a reservoir for rotaviruses and the excreted virus is a source of infection 
for red squirrels. Therefore, to fully elucidate the epidemiology of rotavirus 
infections in red squirrel, detection and monitoring of rotaviruses that circulate 
in both squirrel species are essential. The multiplexity of microarray makes the 
assay a suitable tool for such surveillance and it has the added advantage that it 
can lead to recognition of other viruses in the squirrels.
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Case study 4.4: Unknown febrile horse disease 
In Israel
4.4.1 Introduction
4.4.1.1 Disease history
The outbreak involved an idiopathic febrile infection in horses that lasted 
for 4 months (October 2008 to January 2009) and affected more than 60 equine 
premises across Israel. The disease affected animals of all ages and sexes and the 
morbidity ranged from 2 % to 100 %, with no reported mortality. The infection 
was self-limiting and lasted for 7 to 30 days. Clinical signs consisted of pyrexia, 
oedema in the neck, legs, eyelids and lips. Affected animals showed signs of 
elevated pulse and breathing rates along with mucosal congestion. Unrest and 
decreased appetite were also noted in the affected horses.
4.4.1.2 Preliminary investigation
The preliminary investigation of this outbreak was conducted by David 
Westcott, AHVLA. Samples from affected horses were tested by PCR for a 
number of suspected viruses, which present with similar clinical signs. These 
viruses were equine herpesvirus 1, equine viral arthritis, Getah virus, Venezuelan 
equine encephalitis virus, Ross river virus. Eastern equine encephalitis virus. 
Western equine encephalitis virus, tick borne encephalitis virus, Usutu virus. 
West Nile virus, louping ill virus, dengue hemorrhagic fever virus and Japanese 
encephalitis virus. All the PCR tests proved negative.
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4.4.2 Materials and methods
4.4.2.1 Virus culture and nucleic acid extraction
Virus culture was conducted by David Westcott, AHVLA Weybridge. 
Briefly, the sera from the affected horses were inoculated onto Vero cells 
maintained in Earls' MEM (Invitrogen) supplemented with 7.5 % sodium 
bicarbonate (SIGMA), 5 % lactalbumin hydrolysate, 0.1 M sodium pyruvate 
(GIBCO), 0.2 M glutamine, 10 % antibiotics (penicillin, streptomycin & nystatin; 
Fisher scientific), and 2% foetal calf serum (FCS; Autogen Bioclear). Post 
infection, the cells were grown in Earls MEM with 10 % FCS for 4-5 days. Upon 
reaching 80 % confluency, the cells were trypsinized and centrifuged at 1000 xg 
for 5 minutes and the cell pellet was resuspended in distilled water.
Genomic DNA and RNA in the pellet were digested with a cocktail o f 
nucleases prior to viral nucleic acid extraction as described in section 4 .I.2 .I. The 
viral nucleic acid was extracted with the QiaAmp viral RNA minikit (Qiagen) and 
DNA contaminants further digested with amplification grade DNase I (1 u/pl, 
Invitrogen) as described in section 2.2.2.
4.4.2.2 Microarray
The cDNA and second strand synthesis, sequence independent 
amplification, labelling reaction, and hybridisations were carried out as described 
in section 2.2. BioChip version 4.1 was used in this study.
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4.4.2.3 PCR and phylogenetic analysis
In order to confirm the microarray findings and to characterize the 
detected virus, tiling primers (Table 4.8) were designed on the three probes that 
produced the highest fluorescence intensity in the microarray analysis. These 
probes spanned a region of 296 bases (458 to 754 nt) within the non structural 
(NS) 3 gene of equine encephalosis virus (EEV) field isolate SlFLDl (accession 
number AY115878).
Forward primer (S'- S') Reverse primer (S' -  3') Product 
size (bp)
EEV3 F EEV102_R; AGA AAG GGG TG A TTA  TGA AG (5 5 7  - 5 3 8 ) 99
GCG TG T AAT AAA ACG GGG AG (4 5 8 EEV236_R: TGG AG T GAG A G T GAG AAG G (6 9 1 - 6 7 3 ) 233
-4 7 7 ) ^ EEV265_R: AGT GGT AGG GTA GAT GG ( 7 1 9 - 7 0 3 ) 26 2
EEV299_R: AGG TTT GGG GGA GGG GTA A T (7 5 4  -  73 5 ) 29 6
EEV21 F EEV102 R; AGA AAG GGG TGA TTA  TGA AG 81
AGC GCA GAG AAG AAT GAG C (4 7 6 - EEV236 R: TGG AGT GAG A G T GAG AAG G 215
4 9 4 ) EEV265 R: AGT GGT AGG GTA GAT GG 24 4
EEV299_R: AGG TTT GGG GGA GGG GTA AT 27 8
EEV48 F EEV102 R: AGA AAG GGG TGA TTA  TGA AG 188
TTG ATG AG A TGG A G T GGG G (5 0 3 - EEV236 R: TGG AGT GAG AG T GAG AAG G 21 7
5 2 1 ) EEV265_R: AGT G GT AGG GTA GAT GG 251
' Position on EEV SlFLDl NS3 sequence
Table 4.8: List of tiling primers designed to  collectively amplify a 296 bp stretch 
w ithin the NS3 gene of EEV SlFLDl Isolate (accession number AY115878). The
three probes that produced the brightest fluorescence on the microarray chip 
were located to this region.
PCRs were performed on the randomly amplified microarray templates 
using the Fast Cycling PCR kit as described in section 4.I.2.3. The reaction 
conditions comprised of a 95 °C initial dénaturation step for 5 minutes, followed 
by a 35-cycle amplification of 95 °C for 15 seconds, 50 °C for 15 seconds and 72 
°C for 30 seconds with a final extension of 7 minutes at 72 °C. The amplified
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products were analysed by 1.5 % standard agarose gel electrophoresis and 
amplicons of the expected size were extracted from the gel using the MinElute 
gel extraction kit (Qiagen) before being subjected to sequencing as before 
(section 4.1.2.3). PCR and sequencing were repeated on the cDNA template and 
ambiguous DNA reads were corrected by additional PCR and sequencing. 
Phylogenetic analysis of the DNA sequences was performed with PHYLIP version 
3.68. The confidence values in tree grouping were calculated using bootstrapping 
(2000 replicates).
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4.4.3 Results
4.4.3.1 Microarray analysis
The nucleic acid extracted from the virus isolated in cell culture from the 
serum of the affected horses was randomly amplified, labelled and hybridised on 
the BioChip version 4.1. The microarray analysis revealed the presence of equine 
encephalosis virus (EEV), a member of Orbivirus genus of Reoviridae family, in 
the sample. A mean fluorescence log: ratio o f 5.7 was recorded for the EEV 
probes (p = 0.007) when the fluorescence intensity of the EEV probes were 
compared to those of an uninfected control culture. The signal for other viruses 
in the table was considered as non-specific (Thogoto and adenoviruses) or as a 
result of hybridisation with possibly endogenous and latent viruses (retro and 
herpesviruses). Therefore, these virus hits were not investigated further 
considering the fact that the clinical signs of the diseased horses match those of 
EEV infection. The possibility of equine herpesvirus 1 involvement in the disease 
was already ruled out in the preliminary investigation.
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Viruses detected by the microarray No. of probes t value p value Mean log;
Equine encephalosis virus 1 9 3.00 0.007 5.70
Thogoto virus 7 2.00 0.04 4.10
Pongine herpesvirus 4 6 2.70 0.01 3.10
Human endogenous retrovirus 13 2.10 0.02 1.70
Human adenovirus type 12 9 1.90 0.04 1.60
Table 4.9: Output o f microarray performed on the nucleic acid extracted from 
the virus isolated in cell culture, which was inoculated w ith sera of affected 
horses. The table shows the first 5 top virus hits, the probes of viruses with the 
highest normalised mean log: ratios of feature intensities.
4.4.3.2 PCR and phylogenetic analysis
Three EEV probes that produced the highest fluorescence on the array 
were located within the NS3 gene of EEV SlFLDl isolate (nucleotides 458 to 754) 
and tiling primers were designed to amplify this region. The overlapping primers 
produced amplicons of the expected sizes, which were further verified by 
sequencing (Appendix E).
The sequence comparison of the 296 bases within the NS3 gene unveiled 
the highest homology (89.9 %) to those of field isolates of serotype 1 followed by 
serotypes 7 (89.6 %) and 2 (89.3 %) reported from South Africa (Table 4.10). 
Phylogenetic analysis (Figure 4.9) clustered the Israeli EEV isolate with field (FLD) 
and reference (REF) strains of EEVl, 2,4 and 7.
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Figure 4.9: Phylogenetic analysis of the Israeli EEV isolate. 296 nucleotides of 
the NS3 gene were used in this analysis. Human rotavirus A RV 412 (accession 
number DQ785521.1) was used as an out-group. The phylogenetic tree was 
constructed by PHYLIP 3.68 and the confidence levels were calculated using 
bootstrapping (2000 replicates). Only the bootstrapping percentages above 50 
are shown on the tree. Viruses used in phylogenetic analysis include Bluetongue 
virus (BTV), African horse sickness virus (AHSV), equine encephalosis virus (EEV) 
and epizootic haemorrhagic disease virus (EHDV).
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4.4.4 Discussion
Equine encephalosis virus (EEV), which causes equine encephalosis in 
horses, donkeys and zebras, is classified under the genus Orbivirus in the family 
Reoviridae (Sarkisian et a!., 1979; Guthrie, 2009). EEV is one of 20 different virus 
species recognized to date within this genus. The Orbivirus genus also includes 
BTV, AHSV and EHDV. EEV is closely related to BTV species (Mertens, 2000).
Orbiviruses are named after their distinctive donut shaped capsomeres 
(Gould & Hyatt, 1994; Roy, 1996). The viral particles are spherical and of an 
icosahedral symmetry. Each virion is about 70-80 nm in size, non-enveloped, and 
possess a multi-layered capsid which comprised of outer, intermediate and inner 
layers. The genome is linear and comprised of 10 segments of double-stranded 
RNA encoding 12 viral proteins, namely VPl- 7 (structural) and NSl -  3 (non- 
structural). Proteins VP2 and VP5 constitute the outer capsid, VP7 forms the 
intermediate capsid, and VP3 comprises the inner capsid, o f the virion. The VP2 
protein determines the serotype- specificity of EEV, and is the dominant antigen 
for eliciting an immune response.
Equine encephalosis is a vector borne infection that is transmitted by 
Culicoides midges (Guthrie, 2009). Orbiviruses in general preferentially infect 
vascular endothelial cells via endocytosis (Nancy, 2008). Upon entering the cell, 
the viral particle loses its outer capsid and begins early transcription in which full 
length capped viral mRNA transcripts are synthesized by the viral polymerase. 
Subsequently, the viral mRNAs are translocated into the cytoplasm for 
translation. Concurrently these mRNAs are encapsidated in the sub-viral
157
particles, and converted into double stranded RNA genome. The outer capsid is 
assembled on the sub-viral particles, and the mature virions are released by 
cellular lysis.
Equine encephalosis is a mild to subclinical infection, which so far has 
been endemic to the temperate regions of Africa (Crafford et ol., 2003). The 
infections usually occur during late summer and autumn seasons when the 
climatic conditions favour an abundance of Culicoides (Paweska & Venter, 2004). 
Clinical signs such as fever, ineptness and congestion to mild icterus in mucosal 
membranes are commonly observed. Seven serotypes of EEV have been 
identified and characterized to date in South Africa. They are serotype 1 
(Bryanston), serotype 2 (Cascara), serotype 3 (Gamil), serotype 4 (Kaalplass), 
serotype 5 (Kyalami), serotype 6 (Potchefstroom) and serotype 7 (E21/20) 
(Howell et al., 2002). EEV serotype 1 and 6 cause frequent outbreaks whereas 
serotypes 2, 3, 4, 5 and 7 cause sporadic infections affecting only individual 
animals. Serological surveys have shown that EEV is endemic in equids in most 
parts of South Africa, Botswana, Namibia, Zimbabwe, and Kenya, although the 
exact distribution of each serotype in these countries excluding South Africa is 
unknown (Barnard, 1997; Paweska etal., 1999).
EEV is also frequently isolated as a secondary infectious agent in AHSV 
infected herds (House, 1993; Mellor, 1993; Mellor & Hamblin, 2004). Clinical 
signs of equine encephalosis tend to overlap with those of AHS, especially in case 
of the mild or horse sickness fever form. As a result, differential diagnosis of the 
two diseases is essential for implementation of control measures. Laboratory 
detection of EEV is performed by PCR and serological assays such as ELISA
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(Hamblin et al., 1991). Traditionally, for orbivirus isolation, blood or tissues 
(particularly spleen) of the affected animals were intravenously inoculated into 
embryonated eggs, intracerebrally into 2-day-old mice or isolated in cell culture 
lines. The viruses were then detected by group specific sandwich ELISA. Crafford 
and colleagues (2003) report development of a more reliable and efficient 
method of diagnosis, polyclonal antibody-based sero group specific indirect S- 
ELISA.
For the first time this study reports the presence of EEV outside Southern 
Africa. The presence of the disease outside of its reported niche further 
underlines the value of microarrays as a powerful tool in the investigation of 
emerging viral diseases. In addition, successful application of microarrays to 
rapid resolution of such outbreaks further highlights the need for multiplex 
assays in diagnostic establishments.
The international horse trade, for breeding and racing purposes, is 
predicted to increase (Akinboade et o/., 1980). One of the diseases adversely 
affecting this industry is AHS. The disease causes severe and deadly infection in 
horses. AHS is an OIE list A disease and since its symptoms overlap with those of 
EEV, a distinctive diagnosis of these two viruses is important. A multiplex 
detection technique such as the array described here can be used as a single tool 
to provide differential diagnosis of the two viruses.
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Chapter 5: General discussion
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In the early days of advances in antibiotics and vaccines, some 
scientists envisaged that the book on infectious diseases was to be closed so as 
to free resources for a focus on chronic illnesses. This erroneous belief was short 
lived as new diseases were discovered, for example acquired immune deficiency 
syndrome (AIDS) and BSE, as well as the emergence of drug-resistant bacteria 
such as methicillin-resistant Staphylococcus aureus (MRSA). It also has now been 
recognised that the concept of infectious diseases as always being acute is too 
narrow. Viruses have also been linked to a wide range of chronic illnesses in 
humans, including cancers, cardiovascular diseases and mental illness. Thus, 
despite constant advances in the development of vaccines, antibiotics and 
antiviral drugs the book on infectious diseases remains open and new chapters 
are frequently being added.
Vertebrate species are estimated to be more than 50,000 in number. 
Assuming each vertebrate is associated with only 20 endemic virus species, 
vertebrate viruses would possibly exceed 1 million (Lipkin, 2010). The extent to 
which these viruses pose threats to human and animal health remains unclear. 
This staggering pool of vertebrate viruses can serve as reservoirs for the 
emergence of novel viral pathogens. In order to tackle the problems faced by 
contemporary viral diagnostic tests especially in cases where a divergent viral 
isolate or a potential new viral species is involved, a state of the art diagnostic 
microarray tool with an immense potential to detect both existing and novel 
viruses was envisaged. The overall objective of the BioChip project was to 
develop and validate a generic microarray platform for the identification and 
characterisation of the major notifiable viruses and investigation of diseases of
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unknown aetiology. As a prelude to it, a mini DNA microarray called the LP chip 
encompassing 70mer genotyping probes to the zoonotic lyssaviruses and the 
quarantine CSF viruses was developed. These genotyping probes were designed 
on the 407 bases of the N gene and 190 bases within the E2 gene for lyssaviruses 
and CSFV, respectively. The mini chip successfully detected and characterised all 
the seven genotypes of lyssaviruses and 10 sub-genotypes of CSFV. The LP chip 
was also used to detect and characterise CSFV from tissues of experimentally 
infected pigs, and mixed pestiviral infections. The 70mer oligonucleotide probe 
design has potential to detect divergent strains. This has advantages over other 
designs in which 25mer nucleotide probes are used in resequencing arrays to 
achieve a parallel typing resolution (Wang et al., 2006; Lin, 2007). The signal 
obtained in microarray assays is dependent on the precise complementarity 
between probes and their genetic targets and longer probes (e.g. > GOmer), 
which were used in the LP chip, are more tolerant of sequence mismatches.
The second aim of the project was to apply the pan viral microarray 
(BioChip versions 3.1 and 4.1), developed as part of the BioChip consortium, to 
investigate clinical diseases or syndromes of unresolved aetiology. To achieve the 
second aim, the validated LP chip was incorporated into the BioChip versions 3.1 
and the subsequent version called the 4.1 was used for investigation of the 
unknown diseases. The microarray successfully identified for the first time an 
equine encephalosis virus outside Southern Africa, a new species of rotavirus in 
red squirrels, a porcine neurotropic sapelovirus in pigs and a parvovirus in 
goslings suffering from high mortality.
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The microarray technology in this project employed random amplification 
strategies to allow an unbiased detection of viral targets. As expected, as a 
consequence, host and viral sequences are amplified with similar efficiencies, 
rendering a lower sensitivity for the assay. Host DNA can be eliminated by 
enzymatic digestion, however, host rRNA remains a major challenge (Applied 
Biosystems, 2006). In this study, an enzymatic step was included in the 
microarray procedure to diminish and reduce non- viral genomic content prior to 
nucleic acid extraction, given the notion that viral nucleic acid is likely to be 
protected by the virus capsid. Several methods to  remove rRNA have also been 
described (e.g.; Terminator 5’- phosphate-dependent exonuclease; Epicentre), 
but the value of these interventions remains to be determined. The acceptance 
of microarray use for routine clinical diagnostics will require that the technology 
be accompanied by simple yet reliable analytical methods. DetectiV software, 
developed as part of the Biochip project and used in this study, offers powerful 
yet simple visualisation, normalisation and significance testing capabilities. 
DetectiV also has been shown to perform better than previously developed 
softwares when tested on a large, publicly available dataset (Watson et al., 
2007). This study also provided evidence that array normalisation, use of 
datasets from an uninfected or unrelated sample to correct for background, 
offers a higher degree of robustness and accuracy in identifying viruses. This 
study suggests that this method of normalisation is acceptable for microarray 
data analysis for detection within clinical samples.
The DNA microarray setup described so far in this project has the 
potential to be used as a front line virus detection tool in a routine diagnostic
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environment, as well as in research. However, these chips have certain 
limitations. The probes on these glass chips are spotted in-house, rather than 
printed by commercially acclaimed in-situ synthesis method. Hence, the entire 
probe surface might not be available for template hybridisations, mainly because 
of uneven attachment of probe to the glass surface during printing. Spot 
consistency and slide reproducibility both within and among different batches of 
slides, tend to be one of the limiting factors with the in-house printed microarray 
slides. Likewise, certain probes on the spotted glass chips tend to auto-fluoresce, 
resulting in false positive signal and increased background noise during template 
hybridisation and array analysis. Moreover, feature size and distance between 
adjacent spots poses an impediment towards miniaturisation, for in-house 
printed arrays. All these impediments would also reduce the specificity and 
sensitivity of the microarray in comparison to standard PCR. However these 
limitations can be easily overcome by in-situ probe synthesis such as the non- 
contact inkjet printing (Agilent Technologies) or photo lithographic plating 
(Affymetrix). Usage of other array printable platforms such as chemical/ laser 
etched synthetic polymer, plastic or silicon can further reduce the size of the 
array, thus allowing multiple arrays to be manufactured on one single platform, 
for analysis of more than one sample, simultaneously.
In future. Nanotechnology, which makes use of nano particles 
(NP) of size 1-100 nm, is likely to have a massive role in the future of microarrays 
(Kaittanis et o/., 2010). NPs of various types such as gold & silver NPs, magnetic 
NPs, fluorescent quantum dots (Qdots), and fluorescent polymeric NPs, when 
linked with biological molecules such as antigen, antibody or nucleic acids, act as
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electromagnetic or fluorescent labels in the detection of pathogenic organisms 
from biological samples. These modified NPs due to their aqueous dispersibility, 
biocompatibility, and potential to be detected even in low concentration 
(minimum detection limit of 1 particle), can provide unmatched sensitivity and 
specificity for diagnostic technology. Nanoarrays, utilising these NPs bound to 
specific oligonucleotides, can substitute conventional arrays. These nanoarrays 
can be fabricated using cutting edge technologies such as microfabricated 
surface printing or photolithography (Jain et al., 2005) on a range of diverse 
surface chemistries such as silicon, silanes, hydrogels, or polydimethylsiloxane 
(PDMS). These NP bound probes can be deposited as spots (size 1-30 pm), or 
incorporated via fluidics (Lynch et al., 2004). Smaller size of the array would also 
significantly reduce the volume of the template used for hybridisations. 
Automation of this technology means that multiple samples can be analysed with 
state-of-the art precision, and the processing times can be significantly reduced 
for timely delivery of results. Colorimetric analysis of NPs would also aid in 
interpreting the results with the naked eye and thus would provide significant 
reduction of costs involved in setting up expensive scanners and high-end servers 
for bio-informatic analysis. This would also render them as pen side testing tools 
for quick and timely detection of viruses during outbreaks. Likewise a similar 
technology that could potentially transform microarray diagnostics in to point of 
care detection system is the use of microfluidics (Situma et al., 2006). The 
technology employs usage of an intricate network of micrometer scale chambers 
that serve as a medium for probe-template hybridisations. The microfluidics 
microarrays have the advantage over conventional arrays in terms of reduced
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reagent consumption and low processing times. In addition, these microarrays 
can be designed for parallel processing of multiple samples. The closed 
architecture of the system also minimises the risk of contamination between 
samples. This, in addition to their potential to  integrate several processing steps 
in to a single system, ensures that high levels of automation could be achieved 
for mass sample screening.
In conclusion, in this project a microarray platform was evaluated for its 
potential in parallel detection and typing of viruses and also in detection of re- 
emerging and novel viruses. The platform was successfully applied to detect and 
to type lyssa- and classical swine fever viruses and to recognise re-emerging and 
novel viruses. This project has provided evidence for application of this cost 
effective highly multiplex platform as a frontline detection tool in diagnostic 
establishments for investigation into unknown clinical syndromes.
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T  G A A C A T A T  C A T  T  G G C A C A G G A T  T A A
Appendix A: Case study 1, section 4.1.3.2; Sequence of the amplified product 
obtained in the confirmatory PCR on the spinal cord sample of the pig suffering 
from non suppurative encephalomyelitis.
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Appendix B: Case study 2, section 4.2.33; DNA sequence of the amplicon 
obtained in the GPV fragment A PCR performed on the liver tissue sample of 
the affected gosling.
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Appendix C: Case study 3, Section 4.3.3.2; DNA Sequence of amplicon obtained 
in the rotavirus confirmatory PCR performed on the squirrel faeces sample 
XT854/06.
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Appendix D: Case study, section 4.3.3 2; DNA Sequence of amplicon obtained in 
the rotavirus confirmatory PCR performed on the squirrel faeces sample 85/07.
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Appendix E: Case study 4, section 4.4.3.2; DNA Sequence of the amplicon 
obtained in the PCR performed on the nucleic acid extracted from the virus 
isolated in cell culture that was inoculated with sera of affected horses.
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